Skip Navigation Bar

History of Medicine Finding Aids

National Commission on Acquired Immune Deficiency Syndrome Records 1983-1994
full text File Size: 49 K bytes | Add this to my bookbag

 
Box | Folder Title
 
Series II: Experiment Data, 1949-2003 [series]:
 
Experiments by Series, 1949-2003 [subseries]:
 
AE series, 1975
2 22
AE1, 4/3, 1975
2 23
AE2, 4/4, 1975
2 24
AE3, 4/9 (discarded), 1975
2 25
AE4, 4/10, 1975
2 26
AE5, 4/14, 1975
2 27
AE6, 4/17, 1975
2 28
AE7, 4/28, 1975
2 29
AE8, 5/7, 1975
2 30
AE9, 5/8, 1975
2 31
AE10, 5/19, 1975
2 32
AE11, 5/20 (discarded), 1975
2 33
AE12, 5/22, 1975
 
AMP series, 1976
2 34
AMP -- behavior, 1976
2 35
D-AMP-DG-1, 6/8, 1976
2 36
D-AMP-DG-2, 6/16, 1976
2 37
D-AMP-DG-3, 6/18, 1976
2 38
D-AMP-4, 8/26, 1976
2 39
D-AMP-5, 8/26, 1976
2 40
D-AMP-6, 9/17, 1976
2 41
D-AMP-7, 12/23, 1976
2 42
D-AMP-8, 12/23, 1976
2 43
D-AMP-DG-101, 6/19, 1976
2 44
D-AMP-102, 6/28, 1976
2 45
D-AMP-103, 7/3, 1976
2 46
D-AMP-104, 7/3, 1976
2 47
D-AMP-105, 7/6, 1976
2 48
D-AMP-106, 7/7, 1976
2 49
D-AMP-107, 7/10, 1976
2 50
D-AMP-108, 7/20, 1976
2 51
D-AMP-109, 7/20, 1976
2 52
GU-BR, 1976
3 1
L-AMP-DG-1, 6/12, 1976
3 2
L-AMP-2, 10/22, 1976
3 3
L-AMP-3, 12/20, 1976
3 4
L-AMP-4, 12/21, 1976
3 5
L-AMP-5, 12/22, 1976
3 6
L-AMP-6, 12/22, 1976
3 7
L-AMP-7, 12/23, 1976
3 8
L-AMP-101, 7/12, 1976
3 9
L-AMP-102, 7/12, 1976
3 10
L-AMP-103, 7/15, 1976
3 11
L-AMP-104, 7/17, 1976
3 12
L-AMP-105, 7/17, 1976
 
Antipyrine series, 1969-1976
3 13
Antipyrine [ ]-CBF control 1, 3/29, 1976
3 14
Antipyrine [ ]-CBF control 2, 4/2, 1976
3 15
Antipyrine [ ]-CBF control 3, 4/3, 1976
3 16
Antipyrine c14, [ ]-CBF control 4, 4/5, 1976
3 17
Antipyrine c14, [ ]-CBF control 5, 4/6, 1976
3 18
Antipyrine C14, [ ]-CBF control 6, 4/7, 1976
3 19
Antipyrine partition coefficient in dogs, 1969-1970
3 20
Antipyrine partition coefficient in rats [photograph, negative], 1970
3 21
ARF-8A, LCBF-antip.-1', control, 1975
3 22
Chromatography on antipyrine, undated
3 23
Laplace trsnaforms for antip. Sq. wave, 1975-1976
3 24
Series [ ] --IOD: IODO-antip. part. coeff. in rats -- data corrected, 1976
3 25
Series [ ] --IOD; IODO-antip. part. coeff. in rats -- discarded, 1976
3 26
Technical information on IODO-antipyrine, 1976
 
AR series, 1974-1975
3 27
AR-1, P-30' -- 60 uc, experimental, 1974
3 28
AR-1A, P-30' -- 60 uc control, 1974
3 29
AR-2, P-30' -- 60 uc, experimentals, 1974
3 30
AR-3, P-30' -- 60 uc, experimentals, 1974
3 31
AR-3A, P-30' -- 60 uc, control, 1974
3 32
AR-4, P-30' -- 80 uc, experimentals, 1974
3 33
AR-4A, P-30' -- 80 uc, control, 1974
3 34
AR-5, P-30' -- 80 uc, experimentals, 1974
3 35
AR-5A, P-30' -- 80 uc, control, 1974
3 36
AR-6, P-30' -- 80 uc, experimentals, 1974
3 37
AR-6A, P-30' -- 80 uc, control, 1974
3 38
AR-7, P-30' -- 80 uc, experimentals, 1974
3 39
AR-8, P-30' -- 80 uc, experimentals, 1974
3 40
AR-9, anesthesia -- P-30' -- 80 uc, experimentals, 1974
3 41
AR-10, anesthesia -- P-30' -- 80 uc, experimentals, 1974
3 42
AR-11, experimentals, 11/6, 1975
3 43
AR-12, experimentals, 12/6, 1975
3 44
AR-13, experimentals, 6/16, 1975
 
ARF series, 1974-1976
3 45
ARF1 -- LCBF + BARB, 3/20, 1974
3 46
ARF2 -- LCBF + BARB, 3/20, 1974
3 47
ARF3 -- LCBF + BARB, 3/21, 1974
3 48
ARF4 -- LCBF + BARB, 3/21, 1974
3 49
ARF5, LCBF + BARB, 3/23, 1974
3 50
ARF-6, 6/16, 1975
3 51
ARF-7, 6/19, 1975
3 52
ARF-8, 6/23, 1975
3 53
ARF-11, 6/21, 1976
3 54
ARF-12, 6/21, 1976
3 55
ARF-13, 6/23, 1976
3 56
ARF-14, 6/23, 1976
3 57
ARF-15, 6/30, 1976
3 58
ARF-16, 7/6, 1976
 
ATP series, 1964-1973
3 59
ATP assay protocol, undated
3 60
ATP assays of factor preps., 1966
3 61
Effects of thyroid hormone in vivo on protein biosynthesis -- book 1T, 1964
3 62
Effects of thyroxine in vivo [photographs, negatives], undated
3 63
In vivo effect of T4 on microsomal ATP ase (I), 1971
3 64
In vivo effect of T4 on microsomal ATP ase (2), 1972
3 65
In vivo effect of T4/T3 on microsomal ATP ase (3), 1973
3 66
In vivo effect of T4/T3 on microsomal ATPase (4), 1973
4 1
In vivo experiments, undated
4 2
Microsomal ATP ase -- prep book, 1970
4 3
Microsomal ATP ase 1, Apr. -- Oct., 1970
4 4
Microsomal ATP ase 2, Oct., 1970, 1970-1972
4 5
Microsomal ATP ase 3, 1971-1972
4 6
Microsomal ATP ase 4, 1972-1973
 
Cat series, 1971-1981
4 7
Cat 1, LCGU 30', 1971
4 8
Cat 3, LCGU 35', 1971
4 9
Anest. Cat 4, 1974
4 10
Cat 101, 10/17, 1977
4 11
Cat 102, 10/20, 1977
4 12
Cat 103, 10/27, 1977
4 13
Cat 104, 11/17, 1977
4 14
Cat 105, 11/21, 1977
4 15
Cat 106, 12/1, 1977
4 16
Cat 107, 12/8, 1977
4 17
Cat 108, 12/15, 1977
4 18
Cat 109, 12/21, 1977
4 19
Cat 110, 12/29, 1977
4 20
Cat 111, Jan. 12, 1978
4 21
Cat 112, 1/19, 1978
4 22
Cat 113, 1/26, 1978
4 23
Cat 114, 2/2, 1978
4 24
Cat 115, 2/9, 1978
4 25
Cat 116, 2/23, 1978
4 26
Cat 117, 3/2, 1978
4 27
Cat 118, 3/9, 1978
4 28
Cat 119, 3/14, 1978
4 29
Cat 120, 3/16, 1978
4 30
Cat 121, 3/23, 1978
4 31
Cat 122, 3/24, 1978
4 32
Cat 123, 3/28, 1978
4 33
Cat 124, 3/29, 1978
4 34
Cat awake, rem-4, rem-5, pc-1, 1980
4 35
Cat CBF 2, 1971
4 36
Cat, lumped constant, 1974
4 37
Normal cats, LCBF 1, 1971
4 38
Normal cat CBF 3, 1971
4 39
Normal cat CBF 4, 1971
4 40
Normal cat CBF 5, 1971
4 41
Normal -- CFG cat CBF 6, 1971
4 42
SC-1, r. eye patched + 1 PS (P-45' -- 200 uc), 1973
4 43
SC-1A, both eyes patched (P-45 -- 220 uc), 1973
4 44
Series cat: cats -- 30 min. controls, 1980-1981
4 45
Series SQ, Cat 2 -- 8 -- lumped constant in cats conscious, 1974-1976
4 46
SLC 1 (control for REM), 1975
4 47
SLC-2, control for REM, 1975
4 48
SLC-3, REM sleep cat, 1975
4 49
SLC-4, REM sleep cat, 1975
4 50
SLC-5, REM sleep cat, 1976
4 51
SQ -- Cat 1, anesth., 1974
4 52
SQ -- Cat 2, anesth., 1974
 
Cerebral Blood Flow (CBF) series, 1953-1993
5 1
1 NMACO2 -- CBF series -- air breathing control, 1990
5 2
2 NMACO2 -- CBF series, air breathing control, 1990
5 3
3 NMACO2 -- CBF series, 5% CO2 in air, 1990
5 4
4 NMACO2 -- CBF series, 5% CO2 in air, 1990
5 5
5 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1990
5 6
6 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1990
5 7
7 NMACO2 -- CBF series, 5% C02 in air, 1990-1991
5 8
8 NMACO2 -- CBF series -- air breathing control, 1990
5 9
9 NMACO2 -- CBF series -- air + N methyl arginine, 1990
5 10
10 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1990
5 11
11 NMACO2 -- CBF series -- air + N methyl arginine, 1990-1991
5 12
12 NMACO2 -- CBF series -- 5% CO2 in air, 1990-1991
5 13
13 NMACO2 -- CBF series -- 5% CO2 in air, 1990-1991
5 14
14 NMACO2 -- CBF series -- 5% CO2 in air, 1990-1991
5 15
15 NMACO2 -- CBF series -- air + N methyl arginine, 1991
5 16
16 NMACO2 -- CBF series -- air breathing control, 1991
5 17
17 NMACO2 -- CBF series -- air + N methyl arginine, 1991
5 18
18 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991
5 19
19 NMACO2 -- CBF series -- air breathing control, 1991
5 20
20 NMACO2 -- CBF series -- air + N methyl arginine, 1991
5 21
21 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991
5 22
22 NMACO2 -- CBF series -- air + N methyl arginine, 1991
5 23
23 NMACO2 -- CBF series -- 5% CO2 in air, 1991
5 24
24 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991
5 25
25 NMACO2 -- CBF series -- air breathing control, 1991
5 26
26 NMACO2 -- CBFG series -- air + N methyl arginine, 1991
5 27
27 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991
5 28
28 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991
5 29
29 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine (30 mg/kg), 1991
5 30
30 NMACO2 -- CBF series -- - 5% CO2 + N methyl arginine (30 mg/kg), 1991
5 31
31 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991
5 32
32 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991
5 33
33 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991
5 34
34 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine (30 mg/kg), 1991
5 35
35 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine (30 mg/kg), 1991
5 36
36 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991
5 37
37 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991
5 38
38 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991
5 39
39 NMACO2 -- CBF series -- air + saline, 1991
5 40
40 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine (100 mg/kg), 1991
5 41
41 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991
5 42
42 NMACO2 -- CBF series -- air + N methyl arginine (100 mg/kg), 1991
5 43
43 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991
5 44
44 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg), 1991
5 45
45 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg), 1991
5 46
46 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991
5 47
47 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991
5 48
48 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg), 1991
5 49
49 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg), 1991
5 50
50 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991
5 51
51 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991
5 52
52 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg), 1991
5 53
53 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991
5 54
54 NMACO2 -- CBF series -- air + saline, 1991
5 55
55 NMACO2 -- CBF series -- air + saline (eliminated), 1991
5 56
56 NMACO2 -- CBF series -- air + saline, 1991
5 57
57 NMACO2 -- CBF series -- air breathing control, 1991
5 58
58 NMACO2 -- CBF series -- 5% CO2 in air, 1991
5 59
59 NMACO2 -- CBF series -- 5% CO2 in air, 1991
5 60
60 NMACO2 -- CBF series -- air breathing control, 1991
5 61
61 NMACO2 -- CBF series -- air breathing control, 1991
5 62
62 NMACO2 -- CBF series -- 5% CO2 in air, 1991
5 63
63 NMACO2 -- CBF series -- saline + 5% CO2, 1991
5 64
64 NMACO2 -- CBF series -- saline + air, 1991
5 65
65 NMACO2 -- CBF series -- saline + air, 1991
5 66
66 NMACO2 -- CBF series -- saline + 5%CO2, 1991
5 67
67 NMACO2 -- CBF series -- air + NMA (30 mg/kg), 1991
5 68
68 NMACO2 -- CBF series -- air + NMA (10 mg/kg), 1991
5 69
69 NMACO2 -- CBF series --5% CO2 + NMA (10 mg/kg), 1991
5 70
70 NMACO2 -- CBF series -- air + NMA (10 mg/kg), 1991
5 71
71 NMACO2 -- CBF series -- 5% CO2 + NMA (10 mg/kg), 1991
5 72
72 NMACO2 -- CBF series -- air + NMA (10 mg/kg), 1991
5 73
NMA-73, NMA 10 mg/kg + air, 1992
5 74
NMA-74, NMA 10 mg/kg I.V + air, 1992
5 75
NMA-75, NMA 30 mg/kg I.V. + air, 1992
5 76
NMA-76, NMA 10 mg/kg I.V. + 5% CO2, 1992
5 77
77 NTRO-1, CO2 and saline I.V., 1992
5 78
78 NTRO-2, CO2 and nitro, 1992
5 79
79 NTRO-3, air and nitro 30 mg/kg i.v., 1992
5 80
80 NTRO-4, air and nitro, 1992
5 81
81 NTRO-5, CO2 and nitro, 1992
5 82
82 NTRO-6, CO2 and saline i.v., 1992
5 83
83 NTRO-7, CO2 and saline i.v., 1992
6 1
84 NTRO-8, CO2 and nitro, 1992
6 2
85 NTRO-9, air and nitro, 1992
6 3
86 NTRO-10, CO2 and nitro 30 mg/kg i.v., 1992
6 4
87 NTRO-11, air + nitro 30 mg/kg i.v., 1992
6 5
88 NTRO-12, CO2 and nitro 30 mg/kg i.v., 1992
6 6
89 NTRO-13, air and nitro, 1992
6 7
90 NTRO-14, air and nitro, 1992
6 8
91 NTRO-15, CO2 and nitro, 1992
6 9
92 NTRO-16, CO2 and nitro, 1992
6 10
93 NTRO-17, 5% CO2 and nitro 30 mg/kg, 1992
6 11
95 NTRO-19, 5% CO2 and nitro 30 mg/kg i.v., 1992
6 12
96 NTRO-20, nitro-topical, 1992
6 13
97 NTRO-21, nitro-topical, 1992
6 14
98 NTRO-22, nitro-topical, 1992
6 15
98 NTRO-23, nitro-topical, 1992
6 16
100 NTRO-24s, air and nitro 30 mg/kg, 1993
6 17
101 NTRO-25s, air + nitro 30 mg/kg, 1993
6 18
102 NTRO-26s, 5% CO2 and nitro 30 mg/kg i.v., 1993
6 19
103 NTRO-27s, nitro 30 mg/g i.v. and 5% CO2, 1993
6 20
104 (28), CO2 and NTRO, 1993
6 21
105 (29), CO2 and NTRO, 1993
6 22
106 (30), air and NTRO, 1993
6 23
107 (31), air and NTRO, 1993
6 24
NTRO 108, chronic i.p. and CO2, 1993
6 25
NTRO 109, chronic i.p. and CO2, 1993
6 26
NTRO 110, chronic i.p. and air, 1993
6 27
NTRO 111, chronic i.p. and air, 1993
6 28
NTRO 112, chronic i.p. and air, 1993
6 29
NTRO 113, chronic i.p. and CO2, 1993
6 30
NTRO 114, chronic i.p. and CO2, 1993
6 31
NTRO 115, chronic i.p. and CO2, 1993
6 32
NTRO 116, chronic i.p. and air, 1993
6 33
NTRO 117, chronic i.p. and air, 1993
6 34
NTRO 118, chronic i.p. and air, 1993
6 35
NTRO 119, chronic i.p. and CO2, 1993
6 36
NTRO 120, saline chronic i.p. and CO2, 1993
6 37
NTRO 121, saline chronic i.p. and CO2, 1993
6 38
NTRO 122, saline chronic i.p. and air, 1993
6 39
NTRO 123, saline chronic i.p. and air, 1993
6 40
NTRO 124, saline chronic i.p. and air, 1993
6 41
NTRO 125, saline chronic i.p. and CO2, 1993
6 42
NTRO 126, 1993
6 43
NTRO 127, 1993
6 44
NTRO 128, 1993
6 45
NTRO 129, 1993
6 46
NTRO 130, 1993
6 47
NTRO 131, saline chronic i.p. and CO2, 1993
6 48
NTRO 132, saline chronic i.p. and CO2, 1993
6 49
NTRO 133, saline chronic i.p. and CO2, 1993
6 50
14c-NMA distribution, 1993
6 51
Brain tissue NMA assay, 1992
6 52
Calculations for CBF (Kety-Schmidt), undated
6 53
CBF -- ischemia experiments, 1980
6 54
CBF -- LSD -- normals, 1954-1955
6 55
CBF -- n.20 -- normal young, 1957-1958
6 56
CBF -- nitrous oxide -- Pitressin, 1956
6 57
CBF -- nitrous oxide -- children [photographs], 1957
6 58
CBF -- thyroid disease, undated
6 59
CBF aged -- continued, 1956-1957
6 60
CBF exp., undated
6 61
CBF lysergic acid [photographs], 1955
6 62
Cerebral blood flow, 1957-1958
6 63
Cerebral blood flow -- book II, 1954-1957
6 64
Cerebral blood flow 3, 1955
6 65
Changes in CBF during REM sleep (fig. 3) (from Reivitch, et. al.) [slides], 1977
6 66
Chemical assay in NMA study, 1992
6 67
CO2 study -- local CBF, undated
6 68
CBF -- LSD -- schizophrenia, 1954-1955
6 69
KR 79 CBF studies [photographs], 1953-1955
6 70
Local C.B.F III, 1954-1955
6 71
Local C.B.F. II, 1953-1954
6 72
Local C.B.V IV, 1955-1957
6 73
NMA Co2 series, undated
6 74
NMA2DG series: animal 01 control, 1991
6 75
NMA2DG series: animal 02, exp. NMA 3 mg., 1991
6 76
NMA2DG series: animal 3, exp. NMA 3 mg/kg, 1991
6 77
NMA2DG series: animal 4 control, 1991
6 78
NMA2DG series: animal 05, exp. NMA 3mg/kg, 1991
6 79
NMA2DG series: animal 06 control, 1991
6 80
NMA2DG series: animal 07, exp. NMA 3mg/kg, 1991
6 81
NMA2DG series: animal 08 control, 1991
6 82
NMA2DG series: animal 09 control, 1991
6 83
NMA2DG series: animal 10 control (eliminated), 1991
7 1
NMA2DG series: animal 11 control, 1991
7 2
NMA2DG series: animal 12 control, 1991
7 3
NMA2DG series: animal 13 control, 1991
7 4
NMA2DG series: animal 14, exp. NMA 100 mg/kg, 1991
7 5
NMA2DG series: animal 15, exp. NMA 100 mg/kg, 1991
7 6
NMA2DG series: animal 16 control, 1991
7 7
NMA2DG series: animal 17, exp. NMA 100 mg/kg, 1991
7 8
NMA2DG series: animal 18 control, 1991
7 9
NMA2DG series: animal 19, exp. NMA 100 mg/kg, 1991
7 10
NMA2DG series: animal 20, exp. NMA 100 mg/kg, 1991
7 11
NMA2DG series: animal 21, exp. NMA 100 mg/kg, 1991
7 12
NMACO2 summaries, 1992
7 13
NMA-DG, data sheet, 1991-1992
7 14
Regional cerebral blood flow (Tbl 2) (from Reivitch, et. al.), 1977
 
CI* series, undated
7 15
Ci *(t)/Cp*(t) v.s stretch time (pulse experiments), 1979
7 16
Ci ct/Cp* vs. real time or stretch time -- weighted average, 1979-1985
7 17
Ci*(t)/Cp*(t) vs. stretch time (pulse experiments), undated
7 18
Local tissue 14c concentration (gray) Ci*Ct/Cp* (gray) [folder 1 of 2], 1979-1986
7 19
Local tissue 14c concentration (gray) Ci*Ct/Cp* (gray) [folder 2 of 2], 1979-1986
7 20
Local tissue 14c concentration (white) -- Ci ct/Cp* (white), 1975-1985
7 21
Lt Cp*dt -- pulse exp., 1979
7 22
Pulse (mori) -- local Ci* -- ci*/Cp*, 1979-1984
7 23
Square wave experiments -- Ci*(t)/Cp*(t) vs. stretch time -- vs. real time Ci*(t)/Cp*, undated
7 24
Weighted average -- Ci*(t)/Cp*(t) vs. stretch time -- pulse experiments, 1979
 
CR series, 1972-1976
7 25
CB-4, B-20 uc -- 45', CO2 -- 86', 1975
7 26
CB-5, B-20 uc -- 45', CO2 -- 86', 1975
7 27
CB-6, Pul. -- 20 uc -- 45', CO2 -- 90', 1975
7 28
CB-7, LCGU-45' -- 30 uc, CO2 -- 75', 1975
7 29
CB-8, discarded, 1975
7 30
CB-9, LCGU -- 45' -- 30 uc, CO2 -- 75', 1975
7 31
Series CRO: 5% CO2, 45' exposure, undated
7 32
CR-1, LCGU + CO2, P-30' 80 uc, 1974
7 33
CR-2, LCGU + CO2, P-30' -- 80 uc, 1974
7 34
CR-3, LCGU + CO2, P-30' -- 80 uc, 1974
7 35
CR-4, LCGU + CO2, P-33' -- 90 uc, 1974
7 36
CR-5, LCGU + CO2, P-30' -- 90 uc, 1974
7 37
CR-101, LCGU -- 30' -- 75 uci, CO2 -- 45', 1975
7 38
CR-102, LCGU -- 30' -- 75 uci, CO2 -- 45', 1975
7 39
CR-103, LCGU -- 30' -- 75 uci, CO2 -- 45', 1975
7 40
CR-104, LCGU -- 30' -- 50 uci, CO2 -- 45', 1975
7 41
CR-105, LCGU -- 30' -- 70 uci, CO2 -- 45', 1975
7 42
CRF-1, 85 uc, LCBF + CO2-74 min., 1974
7 43
CRF-2, 85 uc, LCBF + CO2 -- 70', 1974
7 44
CRF-3, 85 uc, LCBF + CO2 -- 45', 1974
7 45
CRF-4, 68 uc, LCBF + CO2 -- 48', 1974
7 46
CRF-5, 68 uc, LCBF + CO2 -- 45', 1974
7 47
CRF-6, 85 uc, LCBF + CO2 -- 41', 1974
7 48
CRF-7, 85 uc, LCBF + CO2 -- 26', 1974
7 49
CRF-8, 85 uc, LCBF + CO2 -- 38', 1974
7 50
CRF-9, 85 uc, LCBF + CO2 -- 43', 1974
7 51
CRF-10, 85 uc, LCBF + CO2 -- 42', 1974
7 52
CRF-11, 85 uc, LCBF + CO2 -- 11', 1975
7 53
CRF-12, 85 uc, LCBF + CO2 -- 12', 1975
7 54
CRF-13, 85 uc, LCBF + CO2 -- 12', 1975
7 55
CRF-14, 85 uc, LCBF + CO2 -- 16', 1975
7 56
CRF-15, 68 uc, LCBF + CO2 -- 14', 1975
7 57
CRF-101, LCBF -- 1', 10% CO2 -- 45', 1975
7 58
CRF-102, LCBF -- 1', 10% CO2 -- 45', 1975
7 59
CRF-103, LCBF -- 1', 10% CO2 -- 45', 1975
7 60
CRF-104, LCBF -- 1', 10% CO2 -- 45', 1975
7 61
CRF-105, LCBF (Ant. 1'), 10% CO2 -- 45', 1975
7 62
Series CRF 111-115 : 10% CO2 + 10' exposure, 1975
7 63
CRF-201, 20% CO2, 1976
7 64
L.C.B.F. : effects of CO2 in puppy, 1972
 
DEX series, 1979
8 1
Dex-1, 1/30, 1979
8 2
Dex-2, 3/12, 1979
8 3
Dex-3, 3/14, 1979
8 4
Dex-4, 3/16, 1979
8 5
Dex-5, 4/19, 1979
8 6
Dex-Px-1 (21 mg/kg), 1/15, 1979
8 7
Dex-Px-2 (21 mg/kg), 3/12, 1979
8 8
Dex-Px-3 (21 mg/kg/min.), 3/14, 1979
8 9
Dex-Px-4 (21 mg/kg), 3/16, 1979
8 10
Dex-Px-5 (21 mg/kg), 3/21, 1979
 
Deoxyglucose (DG) series, 1973-1979
8 11
% of free DG in grey and white matter, 1977
8 12
DG-1, 30' -- B, 1973
8 13
DG-2 (C14), 1973
8 14
DG-3, 45' cont., 1973
8 15
DG-101, 30' -- B, 1973
8 16
DG-102, B -- 30' -- 51 uc, 1973
8 17
DG-103, B-45'-76 uc, 1973
8 18
DG-104, B-45' -- 76 uc, 1973
8 19
DG-105 B-120' (51 uc x 1 1/2'), 1973
8 20
DG-106, B-45' -- 51 uc, 1973
8 21
DG-107 B-120 (51 uc x 1 1/2'), 1973
8 22
DG-108, B-45' -- 51 uc, 1973
8 23
DG-111, B-75' -- 51 uc, 1973
8 24
DG-112, B-75 -- 51 uc, 1973
8 25
DG-113, B-90' -- 51 uc, 1973
8 26
DG-114, B-90' -- 51 uc, 1973
8 27
DG-115, LCGU -- control 45', 1975
8 28
DG-116, LCGU -- control 45' (30 uc), 1975
8 29
DG-117, LCGU -- 30' -- 50 uc, 1975
8 30
DG-118, LCGU -- 30', control, 1975
8 31
DG-119, LCGU -- 30' -- 50 uc, control, 1975
8 32
DG-120, LCGU -- 30' -- 50 uc, control, 1975
8 33
DG-121, normal control 45', 1976
8 34
DG-125, LCGU normal control rat, 30', 1976
8 35
DG-126, LCGU -- normal control rat 45', 1976
8 36
DG-127, LCGU -- normal control, 45', 1976
8 37
DG-128, LCGU -- normal control rat, 45', 1976
8 38
DG-129, LCGU -- normal control rat, 45', 1976
8 39
DG-130, LCGU -- normal control, 30', 1976
8 40
DG-131, LCGU -- normal control, 30', 1976
8 41
DG-132, LCGU normal control, 30', 1976
8 42
DG-133, LCGU -- normal control, 30', 1976
8 43
DG-134, LCGU -- normal control rat, 45' (discarded), 1976
8 44
DG-135, LCGU -- light flow rate of anesthetic gas mixture, 45', 1976
8 45
DG-137, LCGU -- tight mask + high flow rate of anesthetic gas mixture, 30', 1976
8 46
DG-138, normal control rat, 45', 1976
8 47
DG-141, high flow rate of gas mix with tight mask, 30', 1976
8 48
DG-142, low flow rate of gas mix with loose mask, 30', 1976
8 49
DG-143, normal control rat, 45', 1976
8 50
DG-144, normal control rat, 45', 1976
8 51
DG-145, normal control rat, 45', 1976
8 52
DG-146, normal control rat, 45', 1976
8 53
DG-147, normal control rat, 45' (discarded), 1976
8 54
DG-170, 8/16, 1977
8 55
DG-182, 45 min. (C.K.) 7/27, 1978
8 56
DG-183, 30 min. (C.K.) 7/27, 1978
8 57
DG-184, 7/27, 20 min. C.K., 1978
8 58
DG-185, 45 m in. (C.K.) 7/31, 1978
8 59
DG-186, 30 min. (C.K.) 7/31, 1978
8 60
DG-190, 45 min. (C.K.) 9/11, 1978
8 61
DG-191, 9/11, 20' control, 1978
8 62
DG-192, 60 min. (C.K.) 9/14, 1978
8 63
DG-193, 45 min. (C.K.) 9/18, 1978
8 64
DG-194, 90 min. (C.K.) 9/21, 1978
8 65
DG-195, 9/21, 20 min. C.K., 1978
8 66
DG-196, 10/2, 20 min. C.K., 1978
8 67
DG-198, 30 min. (C.K.) 10/5, 1978
8 68
DG-199, 10/16, 20 min. C.K., 1978
9 1
DG-200, 30 min (C.K.) 10/16, 1978
9 2
DG-201, 45 min. (C.K.) 10/19, 1978
9 3
DG-201, 5' -- C -- 51 uc, 1973
9 4
DG-202, 60 min (C.K.) 10/19, 1978
9 5
DG-202., 5' -- C -- 51 uc, 1973
9 6
DG-203, 10' -- C 39 uc, 1973
9 7
DG-203, 90 min. 10/23, 1978
9 8
DG-204, 10' -- C 39 uc, 1973
9 9
DG-204, 60 min. 10/23, 1978
9 10
DG-205, 10' -- C -- 39 uc, 1973
9 11
DG-205, 60 min. control, 1978
9 12
DG-206, 5' -- C 51 uc, 1973
9 13
DG-207, 10' -- C -- 39 uc, 1973
9 14
DG-207, 60 min. 12/22, 1978
9 15
DG-208, 20' -- C -- 34 uc, 1973
9 16
DG-209, 20' -- C -- 34 uc, 1973
9 17
DG-209, 45 min. (C.K.) 12/28, 1978
9 18
DG-210, 20' -- C -- 34 uc, 1973
9 19
DG-210, 30 min 12/28, 1978
9 20
DG-211, 1/4, 20 min. control, 1979
9 21
DG-211, C -- 30' -- 29 uc, 1973
9 22
DG-212, 30' -- C -- 29 uc, 1973
9 23
DG-212, 90 min. 1/11, 1979
9 24
DG-213, 90 min. 1/15, 1979
9 25
DG-213, C -- 30' -- 29 uc, 1973
9 26
DG-214, 90 min. 1/18, 1979
9 27
DG-214, C -- 45' -- 23 uc, 1973
9 28
DG-215, 90 min. 1/18, 1979
9 29
DG-215, C -- 45' -- 23 uc, 1973
9 30
DG-216, C -- 1' -- 68 uc, 1973
9 31
DGX-1, BoP. -- 6 hrs., 1973
9 32
DGX-2, BoP. -- 17 hrs., 1973
9 33
DGX-3, BoP -- 24 hrs., 1973
9 34
Summary of DGX-1, DGX-2, DGX-3 data, 1973
151 1
[DG* and DG*-6-P chart with three time graph printouts, 1974, 1975, 1976
 
DL series, 1971-1973
9 35
DL-X, 1972
9 36
Series DL1 -- DL11 : 20 mg/kg, experimentals, 1971
9 37
Series DL 1A -- DL 11A : 20 mg/kg controls, 1972
9 38
Series DL101 -- DL110 : 100 mg/kg, experimentals, 1971
9 39
Series DL201-DL206 : 50 mg/kg, experimental, 1972
9 40
Series DL207A -- DL215A : 50 mg/kg, controls, 1972
9 41
Series DL208 -- DL211 : 50 mg/kg, experimentals, 1972
9 42
Series DL213 -- DL214 : 50 mg/kg, experimentals, 1975
9 43
Series DL301 and DL302 : 50 mg/kg, experimental, 1972
9 44
Series DL301A -- DL303A : 50 mg/kg, controls, 1972
9 45
Series DL304 -- DL307 : 50 mg/kg, experimentals, 1972
9 46
Series DL306A -- DL309A : 50 mg/kg, controls, 1972-1973
9 47
Series DL-309 : 50 mg/kg, experimentals, 1973
 
E/E series, 1974-1975
9 48
E/E 1and2, discarded, 1974
9 49
E/E 3, 1974
9 50
E/E 4, 1974
9 51
E/E 5, 1974
9 52
E/E 6, 1974
9 53
Rat E/E 7, 1974
9 54
E/E 8, 11/7, 1974
9 55
E/E 9, 11/14, 1974
9 56
E/E 10, 12/12, 1974
9 57
E/E 11, 1974
9 58
E/E 12, 1974
9 59
E/E 13, Jan. 10, 1975
9 60
E/E 14, 1/13, 1975
9 61
E/E 15, 1/17, 1975
9 62
E/E 16, 1/23, 1975
9 63
E/E 17, 1/27, 1975
9 64
E/E 18, 2/6, 1975
9 65
E/E 19, 2/10, 1975
9 66
E/E 20, 2/13, 1975
9 67
E/E 21, Feb. 14, 1975
9 68
E/E 26, and 27, cancelled, 1975
9 69
E/E 29 discarded, 1975
 
G6 series, 1985, 1987
9 70
G6 pase 1, 1985
9 71
G6 pase 2, 1985
9 72
G6 pase 3, 1985
9 73
G6 pase 4, 1985
9 74
G6 pase 5, 1985
9 75
G6 pase 6, 1985
9 76
GA pase 7, 1985
9 77
G6 pase 8, 1985
9 78
G6 pase 9, 1985
9 79
G6 pase 10, 1985
9 80
G6 pase 11, 1985
9 81
G6 pase 12, 1985
9 82
G6 pase 13 -- Aug. 2, 1985
9 83
G6 pase 14, 1985
9 84
G6 pase 15, 1985
9 85
G6 pase 16, 1985
9 86
G6 0ase 17 -- Aug. 5, 1985
9 87
G6 pase 18 -- Aug. 5, 1985
9 88
G6 pase 19 -- Aug. 5, 1985
9 89
G6 pase 20 -- Aug. 5, 1985
9 90
G6 pase 21 -- Aug. 1, 1985
9 91
G6 pase 22 -- Aug. 6, 1985
9 92
G6 pase 23 -- Aug. 6, 1985
9 93
G6 pase 24 -- Aug. 6, 1985
9 94
G6 pase 25 -- Aug. 7, 1985
9 95
G6 pase 26 -- Aug. 7, 1985
9 96
G6 pase 27 -- Aug. 7, 1985
9 97
G6 pase 28 -- Aug, 7, 1985
9 98
G6 pase 29 -- Aug. 8, 1985
10 1
G6 pase 30 -- Aug. 8, 1985
10 2
G6 pase 31 -- Aug. 8, 1985
10 3
G6 pase 32 -- Aug. 8, 1985
10 4
G6 pase 33 -- Aug. 9, 1985
10 5
G6 pase 34 -- Aug. 9, 1985
10 6
G6 pase 35 -- Aug. 9, 1985
10 7
G6 pase 36 -- Aug. 9, 1985
10 8
G6 pase 37 -- Aug. 10, 1985
10 9
G6 pase 38 -- Aug. 10, 1985
10 10
G6 pase 39, 1985
10 11
G6 pase 40, 1985
10 12
G6 pase 41, 1985
10 13
G6 pase 42 -- 60 min. -- Aug. 13, 1985
10 14
G6 pase 43, 1985
10 15
G6 pase 44 -- Aug. 14, 1985
10 16
G6 pase 45 -- 90 min. -- Aug. 14, 1985
10 17
G6 pase 46 -- 2.5 min. -- Aug. 14, 1985
10 18
G6 pase 47 -- 15 min. -- Aug. 14, 1985
10 19
G6 pase 48 -- 60 min. Aug. 16, 1985
10 20
G6 pase 49 -- 30 min. -- Aug. 16, 1985
10 21
G6 pase 50 -- 15 min. -- Aug. 16, 1985
10 22
G6 pase 51 -- Aug. 17, 1985
10 23
G6 pase 52 -- Oct. 16, 1985
10 24
G6 pase 53 -- Oct. 16, 1985
10 25
G6 pase 54 -- Nov. 27, 1985
10 26
G6 pase 55 -- Nov. 27, 1985
10 27
G6 pase 56 -- Nov. 29, 1985
10 28
G6 pase 57 -- Nov. 29, 1985
10 29
G6 pase 58 -- Nov. 29, 1985
10 30
G6 pase P1 -- Aug. 15, 1985
10 31
G6 pase P2 -- Aug. 15, 1985
10 32
G6 pase P3 -- Aug. 16, 1985
10 33
G6 pase P4 -- Aug. 16, 1985
10 34
G6 pase P5 -- Aug. 16, 1985
10 35
G6 pase P6 -- Aug. 27, 1985
10 36
G6 pase P7 -- Aug., 1985
10 37
G6 pase, 1985
10 38
G6 pase -- vol. I -- no. 1 -- no. 13, 1985
10 39
G6 pase -- vol. II -- no. 14 -- no. 25, 1985
10 40
G6 pase -- vol. III -- no. 26 -- no. 37, 1985
10 41
G6 pase -- vol. IV -- no. 38 -- no. 49, 1985
10 42
G6 pase -- P -- vol V, 1985
10 43
G6 pase -- vol. VI -- no. 50, 1985
10 44
G6 pase (square) -- anova, 1987
10 45
Physiological conditions -- G6 pase 1~58, undated
 
HLNC series, 1976
10 46
Helen and Larry normal control series, undated
10 47
HLNC-DG-1, 6/25, 1976
10 48
HLNC-DG-2, 6/25, discarded, 1976
10 49
HLNC-3, 6/28, 1976
10 50
HLNC-4, 7/1, 1976
10 51
HLNC-5, 7/2, 1976
10 52
HLNC-6, 7/6, 1976
10 53
HLNC-7, 7/10, 1976
10 54
HLNC-8, 8/24, 1976
10 55
HLNC-9, 8/24, 1976
10 56
HLNC-10, 10/22, 1976
10 57
HLNC-11, 12/18, 1976
10 58
HLNC-12, 12/18, 1976
10 59
HLNC-13, 12/20, 1976
10 60
HLNC-14, 12/21, 1976
10 61
HLNC-15, 12/22, 1976
 
HIG series, 1977-1978
10 62
HIG-1, 11/28, 1977
10 63
HIG-2, 11/28, 1977
10 64
HIG-3, 12/2, 1977
10 65
HIG-4, 5/11, 1978
10 66
HIG-5, 5/31, 1978
10 67
HIG-NS-1, 1/11, 1978
10 68
HIG-saline-2, 2/7, 1978
10 69
HIG-saline-9, 7/12, 1978
11 1
Nacl-01, 6/22, 1978
11 2
Nacl-03, 7/10, 1978
11 3
Nacl-04, 7/11, 1978
11 4
Nacl-05, 7/12, 1978
11 5
Nacl-3, 2/13, 1978
11 6
Nacl-4, 2/22, 1978
11 7
Nacl-5, 4/4, 1978
11 8
Nacl-6, 4/18, 1978
11 9
Nacl-7, 5/3, 1978
11 10
Nacl-8, 5/10, 1978
 
Hyperglycemia (LC) series, 1980-1987
11 11
LC -- hyperglycemia 1, 15 Jan., 1980
11 12
LC -- hyperglycemia 2, 28 Jan., 1980
11 13
LC -- hyperglycemia 3, Feb. 1, 1980
11 14
LC -- hyperglycemia 4, 2/3, 1980
11 15
LC -- hyperglycemia 5, 2/6 -- Franz, Francesco, Jane, Esther, Sumio, 1980
11 16
LC -- hyperglycemia 6, 2/20, 1980
11 17
LC -- hyperglycemia 7, 3/3 -- Franz, Francesco, Jane, Esther, Sumio, 1980
11 18
LC -- hyperglycemia 8, 3/12 -- Franz, Francesco, Sumio, Dr. Kennedy, Wolfgang, Jane Jehle, Esther, 1980
11 19
LC -- hyperglyc. 9, 3/18 -- Franz, Francesco, Sumio, Jane, Dr. Kennedy, Wolfgang, Esther, 1980
11 20
LC -- hyperglycemia 10, 3/27 -- Franz, Francesco, Sumio, Esther, Wolfgang, Dr. Kennedy, 1980
11 21
LC -- hyperglycemia 11, 3/31 -- Franz, Francesco, Sumio, Dr. Kennedy, Wolfgang, Jane, 1980
11 22
LC -- hyperglycemia 12, 4/22 -- Franz, Francesco, Sumio, Jane Jehle, Esther, 1980
11 23
LC -- hyperglycemia 13, 4/29 -- Franz, Francesco, Sumio, Jane, Esther, 1980
11 24
LC -- hyperglycemia 14, 5/6 -- Franz, Francesco, Sumio, Jane, Esther, 1980
11 25
LC -- hyperglycemia 15, 5/8 -- Franz, Francesco, Sumio, Jane, Esther, 1980
11 26
LC -- hyperglycemia 16, 5/13 -- Franz, Francesco, Jane, Esther, 1980
11 27
LC -- hyperglycemia 17, 5/19 -- Franz, Francesco, Sumio, Jane, Esther, 1980
11 28
LC -- hyperglycemia 18, 5/21 -- Franz, Francesco, Sumio, Jane, 1980
11 29
LC -- hyperglycemia 19, 5/23 -- Franz, Francesco, Sumio, Jane, Esther, 1980
11 30
LC -- hyperglycemia 20, 5/30 -- Franz, Francesco, Jane, Sumio, Esther, 1980
11 31
LC -- hyperglycemia 21, 5/30 -- Franz, Francesco, Jane, Sumio, 1980
11 32
LC -- hyperglycemia 22, 6/9 -- Franz, Francesco, Jane, 1980
11 33
LC -- hyperglycemia 23, 6/11 -- Franz, Francesco, Jane, 1980
11 34
LC -- hyperglycemia 24, 6/16 -- Franz, Francesco, Jane, 1980
11 35
LC -- hyperglycemia 25, 6/19 -- Franz, Francesco, Jane, 1980
11 36
LC -- hyperglycemia 26, 6/25 -- Franz, Francesco, Jane, 1980
11 37
LC -- hyperglycemia 27, 7/1 -- Franz, Francesco, Jane, Esther, 1980
11 38
LC -- hyperglycemia 28, 7/8 -- Franz, Francesco, Sumio, Jane, Esther, 1980
11 39
LC -- hyperglycemia 29, 7/10 -- Franz, Francesco, Jane, Esther, 1980
11 40
LC -- hyperglycemia 30, 7/17 -- Franz, Francesco, Jane, Esther, 1980
11 41
LC -- hyperglycemia 31, 7/21 -- Franz, Francesco, Jane, Esther, 1980
11 42
LC -- hyperglycemia 32, 7/24 -- Franz, Francesco, Jane, Sumio, Esther, 1980
11 43
LC- hyperglycemia -- compiled data, 1980-1987
11 44
LC -- hyperglycemia -- error analyses, counting procedures, etc., 1980
11 45
LC table -- species, undated
 
Iodoantipyrine (IOD) series, 1976-1977
11 46
Iodoantipyrine [ ]-CBF control 1, 4/1, 1976
11 47
Iodoantipyrine [ ]-CBF control 2, 4/2, 1976
11 48
Iodoantipyrine [ ]-CBF control 3, 4/3, 1976
11 49
14c -- iodoantiyprine, [ ]-CBF control 4, 4/6, 1976
11 50
14c -- iodoantipyrine, [ ]-CBF control 5, 4/6, 1976
11 51
14c -- iodoantipyrine -- [ ]-CBF control 6, 4/7, 1976
11 52
Chromatography for 14c -- iodoantipyrine, 7/7, 1976
11 53
Chromatography of iodoantipyrin experiment -- by J. D. Brown, 1976
11 54
Dissolve of 14c -- iodoantipyrine into dioxane phosphov., undated
11 55
IOD-C-7, 14c iodoantiyprine normal cat, 8/19, 1976
11 56
IOD-C-8, 1/6, 1977
11 57
Iodoantipyrine cat normal control 1, 5/6, 1976
11 58
Iodoantipyrine cat normal control 2, 5/14, 1976
11 59
Iodoantipyrine normal CBF cat 3, 5/20, 1976
11 60
Iodoantipyrine normal control 4, 5/27, 1976
11 61
Iodoantipyrine cat normal control 5, 6/4, 1976
11 62
Iodoantipyrine cat normal control 6, 6/11, 1976
11 63
Iodoantipyrine cat study summary, undated
11 64
Iodoantipyrine solubility property, undated
11 65
Iodoantipyrine study summary, undated
11 66
Iodoantipyrine, radiochromatogram -- CFG 1265, 1976
11 67
Iodoantipyrine, radiochromatogram -- CFQ 1460, 1976
 
IP series, 1993
11 68
IPBF 1-4, 1993
11 69
IPBF 5-8, 1993
11 70
IPBF 9-12, 1993
11 71
IPBF 13-16, 1993
11 72
IPBF 17-20, 1993
12 1
IPBF 21-24, 1993
12 2
IPBF 25-28, 1994
12 3
IPBF 29-32, 1994
12 4
IPDG 2 L-NAME, 1993
12 5
IPDG 3 L-NAME, 1993
12 6
IPDG 4 saline, 1993
12 7
IPDG 5, saline, 1993
12 8
IPDG 6, L-NAME, 1993
12 9
IPDG 7, L-NAME, 1993
12 10
IPDG 8, saline, 1993
12 11
IPDG 9, saline, 1993
12 12
IPDG 10, L-NAME, 1993
12 13
IPDG 11, saline, 1993
12 14
IPDG 12, saline, 1993
12 15
IPDG 13, L-NAME, 1993
12 16
IPDG 14, saline, 1993
12 17
IPDG 15, saline, 1993
12 18
IPDG 16, L-NAME, 1993
12 19
IPDG 17, saline, 1993
12 20
IPDG 18, saline, 1993
 
KSA series, 1975-1976
12 21
Antipyrine chromatography, KSA 101 and 102 (plasma), 1975
12 22
Series KSA-0: antipyrine for BDBF pulse inf. for laplace transf., undated
12 23
KSA-101, CBF (K-s) antipyrine, sq. wave 60', 1975
12 24
KSA-102, CBF (K-S) antipyrine, sq. wave 35', 1975
12 25
KSA-103, CBF (K-S) antipyrine, pulse-50 uc-60', 1975
12 26
KSA-103: chromatography on plasma and brain, 1976
12 27
KSA-104 and 105, in brain and plasma, 1976
12 28
KSA-104, discarded, 1976
12 29
KSA-105, discarded, 1976
12 30
KSA-106, discarded, 1976
12 31
KSA-107, discarded, 1976
12 32
KSA-108, discarded, undated
12 33
KSA-109, discarded, 1976
12 34
KSA-110, discarded, 1976
12 35
KSA-114, discarded, 1976
12 35
KSA-118, discarded, 1976
12 37
KSA-119, discarded, 1976
12 38
KSA-120, discarded, 1976
12 39
KSA-124, undated
12 40
KSA-127, discarded, 1976
12 41
KSA-128, discarded, 1977
12 42
KSA-129, normal control (immobilization), 1977
12 43
KSA-131, 5% CO2, CBF, 1977
12 44
KSA-132, normal control, 1977
12 45
KSM-101, methylglucose as tracer for GCBF, 1975
12 46
KSM-102, methylglucose as tracer for GCBF, 1975
12 47
Series KSH: hippuric acid as tracer for GCBF, 1976
12 48
Series KSM1 -- KSM3: methylglucose as tracer for GCBF, 1975
 
Lidocaine (Lido) series, 1978-1979
12 49
Lido-1, 7/24, control, 1978
12 50
Lido-1', 7/24, 1978
12 51
Lido-2, 8/3, 1978
12 52
Lido-3, 8/10, 2 lidocaine, 1978
12 53
Lido-4, 8/10, 1 lidocaine, 1978
12 54
Lido-5, 1/11, saline control, 1979
12 55
Lido-5', 1/11, no seizure history, 1979
12 56
Lido-6, 1/12, saline, 1979
12 57
Lido-6', 1/12, lidocaine, 1979
12 58
Lido-7, 1/19, saline, 1979
12 59
Lido-7', 1/19, lidocaine, 1979
12 60
Lido-8, 1/25, saline, 1979
12 61
Lido-8', 1/25, lidocaine, 1979
12 62
Lido-9, 1/26, saline, 1979
12 63
Lido-9' (experimental animal) 1/26, 1979
12 64
Lido-10, 2/1, saline control, 1979
12 65
Lido-10', 2/1, lidocaine, 1979
12 66
Lido-11, 2/2, saline control, 1979
12 67
Lido-11', 2/2, lidocaine, 1979
12 68
Lido-12, 2/15, saline, 1979
12 69
Lido-12', 2/15, lidocaine, 1979
12 70
Lido-13, saline, 2/16, 1979
12 71
Lido-13', lidocaine, 2/16, 1979
12 72
Lidocaine summary, 1979
 
Glucose Utilization (LCGU) series, 1977-1987
12 73
Cerebral structure w/ signif. changes in LCGU at higher doses of D-LSD, 1976-1977
12 74
Effects of LSD on LCGU in individual structures as a function of dose, undated
12 75
Experiments -- hyperglycemia R.C. average, 1984
12 76
Free moving immobilization on LCGU and LCBF, 1978
12 77
Glucose / LCGU : from 0' -- 120', undated
12 78
Hyperglycemia LCGU experiments -- excluded and misc. [folder 1 of 2], 1980-1982
13 1
Hyperglycemia LCGU experiments -- excluded and misc. [folder 2 of 2], 1980-1982
13 2
Hyperglycemia LCGU experiments -- used and tables, 1982
13 3
Hyperglycemia LCGU experiments 450, 1984
13 4
Hyperglycemia LCGU experiments 450 (programming changes), 1984
13 5
Hyperglycemia LCGU experiments 550A, 1984
13 6
Hyperglycemia, 2DG, 450's, 1984
13 7
L.C.G.U. (pulse exp.) parameters: new 3 rate constants, 1986
13 8
L.C.G.U. (pulse experiments) from Dr. Shinohara's data representative structures, 1977
13 9
LCGU -- pulse experiments -- LC=0.483 -- parameters: new 3 rate constants, 1986
13 10
LCGU -- sandro, undated
13 11
LCGU -- taro, undated
13 12
LCGU (pulse experiments) -- 5 rate constants (K4*=0.002), 1986
13 13
LCGU (pulse experiments) Shinohara series -- graphs -- representative structures, 1977
13 14
LCGU (pulse) parameters 5 rate constants (K4*=0.0014), 1986
13 15
LCGU (square exp.) parameters 5 rate constants (K4*=0.001), 1986
13 16
LCGU (square wave experiments) graphs, undated
13 17
LCGU (square wave experiments) gray structures, undated
13 18
LCGU (square wave experiments) white structures, undated
13 19
LCGU hyperglycemia experiments -- Franz, Francesco, 1980
13 20
LCGU pulse experiments -- 5 rate constants (K4*=0.001), 1986
13 21-23
Local Cerebral Glucose Utilization, 1987
13 24
Shinohara pulse data -- LCGU w/5 -- H model -- K4=.002, K5=.05, 1986
13 25
Spinal cord (sleep) -- LCGU, undated
13 26
Summary of LCGU (pulse) with original rate constants, 1987
13 27
Summary of local LCGU -- square wave exp., undated
13 28
Table for LCGU value, undated
13 29
The effect of NMA on LCGU in the rat, undated
13 30
Weighted average LCGU -- pulse experiments, undated
 
LS series, 1977-1979
14 1
LS-11, general, 8/29, 1978
14 2
LS-II-1, 1977
14 3
LS-II-2, 11/8, 1977
14 4
LS-II-3, 11/8, 1977
14 5
LS-II-4, 11/8, 1977
14 6
LS-II-5, 11/10, 1977
14 7
LS-II-6, 11/11, 1977
14 8
LS-II-7, 11/11, 1977
14 9
LS-II-8, 12/9, 1977
14 10
LS-II-9, 12/9, 1977
14 11
LS-II-10, 12/9, 1977
14 12
LS-II-11,12,13, 2/24, 1978
14 13
LS-II-14,15,16, 4/3, 1978
14 14
LS-II-17, 4/7, 1978
14 15
LSB-2, 1979
14 16
LSB-3, 1977
14 17
LSB-4, 1977
14 18
LSB-5, 1977
14 19
LSB6-10, 1977
 
MG series, 1973, 1988-1989
14 20
Extracting rat brain containing 3H-MG with hexane and chloroform by H. Nakanishi, 1988-1989
14 21
HIGH std.-2, 14c-MG, 10/2, 1978
14 22
HIGH-STD-3, 14c-MG, 10/2, 1978
14 23
MG and hypothalam atlas [computer disk], undated
14 24
MG series '73, 1973
14 25
MG-1, 5' cont., 1973
14 26
MG-2, 10' -- cont., 1973
14 27
MG-3, 20' -- cont., 1973
14 28
MG-4, 30' -- cont., 1973
14 29
MG-5 (C14), 2 hrs., 1973
14 30
MG-6 (C14), 1 min., 1973
14 31
MG 7 (C14), 15' cont., 1973
14 32
MG-8 (C14), 60' cont., 1973
14 33
MG-9, 45' cont., 1973
14 34
MG-10 (C14), 4' -- cont., 1973
14 35
MG-11 (C14), 45' -- cont., 1973
14 36
MG-12 (C14), 40' -- bol. C.S.F., 1973
14 37
MG-13 (C14), 4' -- cont., 1973
14 38
MG-14 (C14), 50' -- bol. C.S.F., 1973
14 39
MG-15, 75' -- bol. C.S.F., 1973
14 40
MG-16, 120' -- bol. C.S.F., 1973
14 41
MG-17, 60' -- bol. C.S.F., 1973
14 42
MG-18, 240' -- bol. C.S.F., 1973
14 43
MG-101 and 102, 30' -- B -- 51 u., 1973
14 44
MG-103 and 104, 45' -- B -- 76 uc., 1973
14 45
MG-105, B -- 120' -- 51 uc., 1973
14 46
MG-106 and 107, B -- 45' -- 51 uc., 1973
14 47
MG-108, B -- 120' -- 51 uc., 1973
14 48
MG-109 and 110, B -- 60 -- 51 uc., 1973
14 49
MG-111 and 112, B -- 75' -- 51 uc., 1973
14 50
MG-113 and 114, B -- 90' -- 51 uc., 1973
 
MSG series, 1978
14 51
MSG-01, 6/22, 1978
14 52
MSG-03, 7/10, 1978
14 53
MSG-04, 7/11, 1978
14 54
MSG-05, 7/11, 1978
14 55
MSG-06, 7/12, 1978
14 56
MSG-07, 7/12 (experiment stop), 1978
14 57
MSG-1, 1/11, 1978
14 58
MSG-2, 2/7, 1978
14 59
MSG-3, 2/13, 1978
14 60
MSG-4, 2/25, 1978
14 61
MSG-5, 4/4, 1978
14 62
MSG-6, 4/18, 1978
14 63
MSG-7, 5/3, 1978
 
NA24 series, 1956-1957
14 64
Bankson, Frederick N.C. -- LBF -- Na24, 1956
14 65
Binkley, Linda N.C. -- LBF -- Na24, 1956
14 66
Brandt, Mildred N.C. -- LBF -- Na24, 1957
14 67
Buck, Jean PN -- LBF -- Na24, 1956
14 68
Busenitz, Donald N.C. -- LBF -- Na24, 1956
14 69
Dunmeyer, Lloyd, M.Dy. -- LBF -- Na24, 1956
14 70
Flickner, Irma N.C. -- LBF Na24, 1957
14 71
Goosen, Warren N.C. -- LBF -- Na24, 1956
14 72
Grim, Nancy N.C., 1957
14 73
Johnson, James M.Dy. -- LBF -- Na24, 1957
14 74
Kelley, Edward M.Dy. -- LBF -- Na24, 1957
14 75
Kidder, Helen PN -- LBF -- Na24, 1956
14 76
Merediz, Laura M.Dy. -- LBF -- Na24, 1956
14 77
Merkey, Phoely N.C. -- LBF -- Na24, 1957
14 78
NA24, 1954
14 79
Na24 -- leg blood flow studies, 1956
14 80
Na24 -- leg blood flow studies -- book 2, 1957
14 81
Peters, A. Joan M.Dy. -- LBF -- Na24, 1957
14 82
Peters, B. Jean M.Dy. -- LBF -- Na24, 1957
14 83
Smith, Ivan N.C. -- LBF -- Na24, 1957
14 84
Steider, Kenneth -- LBF -- Na24, 1956
14 85
Tillman, Joseph P. N. -- LBF -- Na24, 1956
14 86
Wells, John Sch. -- LBF -- Na24, 1956
14 87
Williams, Esther N.C. -- LBF -- Na24, 1956
14 88
Wingert, John N.C. -- LBF -- Na24, 1956
 
New born monkey (NBM) series, 1970-1979, 1983-1989
14 89
Assay of monkey blood, 1978
14 90
LCM 6, 9/30, 1976
14 91
LCM-7, 10/14, 1976
14 92
LCM 9, 11/18, 1976
14 93
Monkey K-732-1, 1971
14 94
Monkey K739-2, 1971
14 95
Monkey lumped constant study, no. 1 [photograph], 1976
14 96
Monkey lumped constant study, no. 2, 1976
14 97
Monkey lumped constant study, no 3, 1976
14 98
Monkey lumped constant study, no 4, 1976
14 99
Monkey lumped constant study, no. 5, 1976
14 100
Monkey-control -- misc., 1985-1989
14 101
NBM-101, tarsoraphy at. 2 days, 1976-1985
14 102
NBM-2, rt. eye patched (LCGU) 11/24, 1978
14 103
NBM-3, LCGU 3, 1976-1977
14 104
NBM-4 [diskette], 1983
14 105
NBM4, new born monkey, LCGU-control, 1976
14 106
NBM-5, 3/15 (LCGU control), 1976
15 1
NBM-6, LCGU, 3/22, 1976
15 2
NBM7 (new born monkey control), 1976
15 3
NBM-8, LCGU-30', r. eye patched, 1978
15 4
Newborn monkey, LCGU control (NBM1), 1976
15 5
PEN. SEIZ.: adult monk. controls + experimentals, 1970
15 6
PEN. SEIZ.: newborn monk. experimentals, 1970
15 7
PEN. SEIZ: newborn monkeys controls, 1970
15 8
Pen-C, 1, 1975
15 9
Series S.M.: laplace transform, 2-DG conscious monkeys, 1976
15 10
Statist. -- new born monkey, 1979
15 11
Stimulated monkey -- summary tables and graphs, undated
 
PCP series, 1986-1987
15 12
PCP-1 -- 10 mg/kg, 1986
15 13
PCP -- 2 Saline 0.36, 1986
15 14
PCP -- 3 1 mg/kg, 1988
15 15
PCP -- 4 N. Saline, 1986
15 16
PCP -- 5 0.3/kg, 1986
15 17
PCP -- 6 3mg/kg, 1986
15 18
PCP -- 7 1mg/kg, 1987
15 19
PCP -- 8 0.1mg/kg, 1987
15 20
PCP -- 9 10mg/kg, 1987
15 21
PCP -- 10 N.S., 1988
15 22
PCP -- 11 3mg/kg, 1986
15 23
PCP -- 12 0.3mg/kg, 1986
15 24
PCP -- 13 1mg/kg, 1987
15 25
PCP -- 14 0.1mg/kg, 1987
15 26
PCP -- 15 3.0mg/kg, 1987
15 27
PCP -- 16 N.S., 1987
15 28
PCP -- 17 0.3mg/kg, 1986
15 29
PCP -- 18 10mg/kg, 1986
15 30
PCP -- 19 N.S., 1986
15 31
PCP -- 20 0.1mg/kg, 1987
15 32
PCP -- 21 0.3/kg, 1987
15 33
PCP 21-2, 1987
15 34
PCP -- 22 3mg/kg, 1987
15 35
PCP -- 23 10mg/kg, 1987
15 36
PCP -- 24 N.S., 1987
15 37
PCP -- 25 1mg/kg, 1986
15 38
PCP -- 26 10mg/kg, 1987
15 39
PCP 27 0.3mg/kg, 1987
15 40
PCP 28 0.1mg/kg, 1988
15 41
PCP Data, 1987
15 42
PCP Raw Data, 1986
 
PT series, 1949-1950, 1979-1987
15 43
PT series -- scp*(t)/cp* -- scp*dt/T, 1949-1950
15 44
Pulse 2DG experiments -- PT series -- Ken Mori StCp*(t)dt, 1986
15 45
PT series plus experiments -- physiological conditions, 1987
15 46
Summary PT series -- stretch time etc., pulse exp. mori, 1979-1986
15 47
PT-2 -- 60 min. -- July 25, 86, 1980-1986
15 48
PT-6 -- 35 min. -- July 26, 86, 1980-1986
15 49
PT-7 -- 120 min. -- Aug. 4, 86, 1980-1986
15 50
PT-8 -- 60 min. -- Aug. 4, 86, 1980-1986
15 51
PT-9 -- 25 min. -- Aug. 4, 86, 1980-1986
15 52
PT-10 -- 90 min. exp. -- Aug. 5, 86, 1980-1986
15 53
PT-11 -- 35 min. exp. -- Aug. 5, 86, 1980-1986
15 54
PT-12 -- 45 min. exp. -- Aug. 5, 86, 1980-1986
15 55
PT-13 -- 120 min. exp. Aug. 86, 1980-1986
15 56
PT-14 -- 60 min. -- Aug. 6, 86, 1980-1986
15 57
PT-15 -- 25 min. -- Aug. 6, 86, 1980-1986
15 58
PT-16 -- 90 min. exp. -- Aug. 7, 86, 1980-1986
15 59
PT-17 -- 45 min. exp. -- Aug. 7, 86, 1980-1986
15 60
PT-18 -- 35 min. exp. -- Aug. 7, 86, 1980-1986
15 61
PT-20 -- 60 min. exp. -- Aug. 8, 86, 1980-1986
15 62
PT-21 -- Aug. 8, 86, 1985-1986
15 63
PT 22 -- 120 min. exp. -- Aug. 11, 86, 1980-1986
15 64
PT 23 -- 90 min. exp. -- Aug. 11, 1986
15 65
PT 24 -- 4-5 min. exp. -- Aug. 11, 1986
15 66
PT-25 -- 120 min. exp. -- Aug. 13, 86, 1985-1986
15 67
PT-26 -- 90 min. exp. -- Aug. 13, 1986
15 68
PT-27 -- 35 m in. exp. -- Aug. 13, 86, 1985-1986
15 69
PT-28 -- 45 min. exp. -- Aug. 14, 86, 1985-1986
15 70
PT-29 -- 25 min. exp. -- Aug. 14, 86, 1985-1986
15 71
PT-31 -- 25 min. -- Nov. 17, 86, 1985-1986
15 72
PT-32 -- 90 min. -- Nov. 18, 1986
15 73
PT-33 -- 25 min. -- Nov. 18, 86, 1985-1986
15 74
PT-34- 45 min. exp. -- Nov. 24, 86, 1985-1986
15 75
PT-35 -- 35 min. exp. -- Nov. 24, 86, 1985-1987
15 76
PT-36 -- 35 min. -- Nov. 24, 86, 1985-1987
15 77
PT-37 -- 45 min. -- Nov. 25, 86, 1985-1987
15 78
PT-38 -- 35 min. -- Nov. 25, 86, 1985-1987
15 79
PT-39 -- 45 min. exp. -- Nov. 26, 86, 1985-1986
15 80
PT-40 -- 25 min. exp. -- Nov. 26, 86, 1985-1986
15 81
PT-41 -- 25 min. exp. -- Nov. 26, 86, 1985-1986
15 82
PT-42 -- 60 min. exp. -- Nov. 28, 86, 1985-1986
15 83
PT-43 -- 35 min. exp. -- Nov. 28, 86, 1985-1987
15 84
PT-44 -- 45 min. exp. -- Nov. 28, 86, 1985-1987
15 85
PT series -- parameters with new three rate constants -- K1*=0.232, K2*=0.240, K3*=0.061, 1985-1986
 
PX series, 1978
15 86
PX-0 (.42 mg/kg), 5/3, 1978
15 87
PX-01 (.42 mg/kg), 8/21, 1978
15 88
PX-02 (.42 mg/kg), 8/21, 1978
15 89
PX-1 (21 mg/kg, 8.6 mg pulse), 2/8, 1978
15 90
PX-2 (7.8 mg pulse), 2/29, 1978
15 91
PX-3 (8.5 mg pulse), 2/29, 1978
15 92
PX-4 (21 mg/kg, 8.2 mg pulse), 3/15, 1978
16 1
PX-5 (4.2 mg/kg), 3/30, 1978
16 2
PX-6 (4.2 mg/kg), 3/30, 1978
16 3
PX-7 (4.2 mg/kg), 4/5, 1978
16 4
PX-8 (4.2 mg/kg), 4/12, 1978
16 5
PX-9 (42 mg/kg), 4/12, 1978
16 6
Px-10, 4/19, 1978
16 7
Px-11, 4/19, 1978
16 8
PX-12 (4.2 mg/kg), 4/27, 1978
16 9
PX-13 (4.2 mg/kg), 5/9, 1978
16 10
PX-14 (42 mg/kg), 5/9, 1978
16 11
PX-15 (4.2 mg/kg), 8/21, 1978
16 12
PX-16 (21 mg/kg), 8/21, 1978
16 13
PX-17 (42 mg/kg), 8/25, 1978
16 14
PX-18 (9 mg/kg), 12/10, 1978
16 15
PX-19 (9 mg/kg), 12/10, 1978
16 16
PX-20 (9 mg/kg), 12/11, 1978
16 17
PX-21 (9 mg/kg), 12/22, 1978
16 18
PX-22 (9 mg/kg), 12/13, 1978
 
SM series, 1973-1985
16 19
SM-1, B-45'-320 ul -- rt. eye covered and wurtz, 1975
16 20
Series SM-2: unilateral patching, 1973
16 21
SM-2A, B'-45'-100 uc, both eyes opened, 1973-1978
16 22
SM-3, P-45'-250 uc. (rt. eye patched), 1973-1975
16 23
SM-3A, visual: rt. eye removed, P-45'-250 uc, 1973-1975
16 24
SM-4A, both eyes opened and wurtz pattern -- P-45'-300 uc, 1973-1975
16 25
Series SM-5: both eyes patched, 1975
16 26
SM-6, 45'-300 mc -- both eyes patched, 1974-1975
16 27
Series SM-7: eyes intact + stimulation, 1974
16 28
SM-8A, 1974-1977
16 29
Series SM-9A: eyes intact + stimulation, 1975-1977
16 30
SM-10, both eyes intact and wurtz pattern, 1974-1975
16 31
SM-11, 1978
16 32
SM-11, both eyes intact and wurtz, pattern, 1974-1977
16 33
Series SM-12: eyes intact + stimulation, 1974-1977
16 34
SM-13, left eye removed and wurtz, 1974
16 35
SM-14, 5/1, rt. eye removed and ambient light, 1975
16 36
Series SM-15: unilateral enucleation, 1975
16 37
Series SM-16: unilateral enucleation, 1975
16 38
SM-17, 8/7 -- left eye patched and wurtz, 1975
16 39
Series SM-18: unilateral enucleation, undated
16 40
SM-19, 11/6 -- left eye patched and wurtz, 1975
16 41
SM-20, 11/20 -- left eye patched and wurtz, 1975
16 42
SM-21, Dec. 23 -- rt. eye patched and wurtz [photograph], 1975
16 43
SM-22, Dec. 23 -- left eye removed and wurtz, 1975
16 44
SM-23, Jan. 23 -- both eyes open, 1976
16 45
SM-24, both eyes patched, Feb. 5, 1976
16 46
SM-25, 2/19 -- rt. eye patched and wurtz, 1976
16 47
SM-26, 3/19 -- rt. eye patched and wurtz, 1976
16 48
SM-27, 5/28 -- both eyes opened and wurtz, 1976
16 49
SM-28, Aug. 2, 1976
16 50
SM-29, 11/4, 1976
16 51
SM-30, 12/9, 1976
17 1
SM-31, 1976-1985
17 2
SM-32, 1/18, 1977
17 3
SM33 and SM24, densitometry, undated
17 4
SM-33, 8/4, both eyes occluded, 1977
17 5
SSM-1/SSM-3, undated
17 6
SSM-2, 1979
17 7
SSM-2, 4/7 [diskette], 1977
17 8
SSM-4 (rt. optic tract sectioned), 1977
17 9
SSM-4 [8" computer disk], 1979
 
SR series, 1973-1974
17 10
Series SR-1: visual alterations, 1973
17 11
Series SR-1A: visual alterations, 1973
17 12
Series SR-2: visual alterations, 1973
17 13
Series SR-2A: visual alterations, 1973
17 14
Series SR-3: visual alterations, 1973
17 15
Series SR-3A: visual alterations, 1973
17 16
SR-3B (l. eye remove), 1973
17 17
SR-4-I (r-eye remove), 1973
17 18
SR-4-II (l-eye remove), 1973
17 19
S.R.-5, (left eye patched, TOT -- darkness, I.P.S.), 1973
17 20
Series SSR: sciatic nerve stimulation, 1974
 
Thyroxine series, 1954-1975
17 21
Reprints -- thyroxine, 1956
17 22
Summaries of thyroxine mitochondrial factor studies, 1964-1965
17 23
Summaries thyroxine effects on pyridine nucleotides, 1975
17 24
T4 effect on mitochondrial NAD+, 1970
17 25
Thyroxine -- illustrations [photographs, negatives], undated
17 26
Thyroxine -- protein synthesis, 1955-1965
17 27
Thyroxine -- protein synthesis in vivo, 1963-1964
136 8-9
Thyroxine -- Protein Synthesis -- Index, undated
17 28
Thyroxine -- uptake by brain, 1954-1955
17 29
Thyroxine analogues [photographs, negatives], 1963
17 30
Thyroxine effects on NAD+, 1974
17 31
Thyroxine effects on pyridine nucleotides -- amino-chance scans [folder 1 of 3], 1974-1975
17 32
Thyroxine effects on pyridine nucleotides -- amino-chance scans [folder 2 of 3], 1974-1975
17 33
Thyroxine effects on pyridine nucleotides -- amino-chance scans [folder 3 of 3], 1974-1975
17 34
Thyroxine effects on pyridine nucleotides, 1974
17 35
Thyroxine experiments, 1964
18 1
Thyroxine experiments -- book 2, 1957-1958
18 2
Thyroxine experiments -- book 3, 1958
18 3
Thyroxine factor [negatives], undated
18 4
Thyroxine iodine studies, 1954-1955
18 5
Thyroxine mechanism -- tables and illus. [photographs, negatives], undated
136 10
Thyroxine-Mitochondrial Factor -- Index [includes slides], undated
18 6
Thyroxine project -- charts and slides [photographs, negatives], undated
18 7
Thyroxine project -- charts and slides [photographs, negatives], undated
18 8
Thyroxine solutions, 1959-1964
18 9
Thyroxine solutions II, 1965-1972
18 10-12
Thyroxine-mitochondrial factor -- preparations and properties -- book 1, 1966-1968
 
Whisker barrel (WB) series, 1991-1993
18 13
WB i.v. study, statistics, 1992
18 14
01 whisker barrel series: control, 1991
18 15
WB-02 experiment NMA 30 mg/kg, 1991
18 16
WB-03 control, 1991
18 17
WB-04, control, 1991
18 18
WB-05, experiment NMA 30 mg/kg, 1991
18 19
WB-06, exp. normal saline 1.1 ml, 1991
18 20
WB-07, exp. NMA 30 mg/kg, 1991
18 21
WB-08, exp. NMA 30 mg/kg, 1991-1992
18 22
WB-09, control, 1991
18 23
WB-09, control, 1991
18 24
WB-11, exp. NMA 30 mg/kg, 1991
18 25
WB-12, NMA 100 mg/kg, 1991
18 26
WB-13, NMA 100 mg/kg, 1991
18 27
WB-14, NMA 100 mg/kg, 1991
18 28
WB-15, NMA 100 mg/kg i.v., 1991
18 29
WB-16, control (saline + no stimulation), 1991
18 30
WB-17, NMA 30 mg/kg i.v., 1991-1992
18 31
WB-18, control, 1991-1992
18 32
WB-19, saline i.v. + no stimulation, 1991
18 33
WB-20, control, 1991
18 34
WB-21, control, 1991-1992
18 35
WB-22, methyl ester, 1992
18 36
WB-22, methyl ester 30 mg/kg i.v., 1992
18 37
WB-24, control, 1992
18 38
WB-25, NAME, 1992
18 39
WB-26, control (saline i.v. and no stimulation), 1992
18 40
WB-27, NAME, 1992
18 41
WB-28, control, 1992
18 42
WB-29, control, 1992
18 43
WB-30, nitro-L-arginine methylester, 1992
18 44
WB-31, control, 1992
18 45
WB-32, nitro-L-arginine methylester, 1992
18 46
WB-33, NAME, 1992
18 47
WB-34, control, 1992
18 48
WB-35, nitro-L-arginine methylester, 1992
18 49
WB-36, nitro, fast infusion, 1992
18 50
WB-37, control, 1992
18 51
WB-38, nitro-L-arginine M.E., 600 ug/rat, 1992
18 52
WB-39, control (DIR), 1992
18 53
WB-40, nitro (direct), 600 ug/rat, 1992
18 54
WB-41, control (direct), 1992
18 55
WB-42, nitro-L-arginine (direct), 1992
18 56
WB-43, nitro-L-arginine, 600 ug/rat, 1992
18 57
WB-44, control, 1992
18 58
WB-45, nitro-L-arginine, 600 ug/rat, 1992
18 59
WB-46, nitro-L-arginine, 600 ug/rat, 1992
18 60
WB-47, control, 1992
18 61
WB-48, control, 1992
18 62
WB-49, nitro-L-arginine, 600 ug/rat, 1992
18 63
WB-50, control, 1992
18 64
WB-51, nitro-L-arginine, 600 ug/rat, 1992
18 65
WB-52and53, 3H-nitro-L-arginine and intracisternal infusion, 1993
18 66
WB-54, chronic and NAME, 1993
18 67
WB-55, chronic i.p. and NAME, 1993
18 68
WB-56, chronic ad of NAME, 1993
18 69
WB-57, chronic i.p., 1993
18 70
WB-58, chronic i.p., 1993
18 71
WB-59, chronic i.p., 1993
18 72
WB-60, L-NAME chronic i.p., 1993
18 73
WB-61, chronic i.p., 1993
18 74
WB-62, chronic i.p., 1993
18 75
WB-63, saline chronic i.p., 1993
18 76
WB-64, saline chronic i.p., 1993
18 77
WB-65, saline chronic i.p., 1993
18 78
WB-66, saline chronic i.p., 1993
19 1
WB-cisternal infusion, 1992
19 2
WBDG -- DG parity check, 1992
19 3
WBDG-1, 1992
19 4
WBDG-2, 1991-1992
19 5
WBDG-3, 1991-1992
19 6
WBDG-4, 1992
19 7
WBDG-5, 1992
19 8
WBDG-6, 1992
19 9
WBDG-7, 1992
19 10
WBDG-8, 1992-1993
 
YOH series, 1978
19 11
YOH-1 (.25 mg/kg/min.), 4/5, 1978
19 12
YOH-3 (.25 mg/kg/min.) 7/10, 1978
19 13
YOH-4 (.25 mg/kg/min.), 7/10, 1978
19 14
YOH-5 (.1 mg/kg/min.), 7/11, 1978
19 15
YOH-6 (.25 mg/kg/min.), 7/11, 1978
19 16
YOH-7 (.1 mg/kg/min.), 7/11, 1978
19 17
YOH-10 (.25 mg/kg/min.), 8/19, 1978
19 18
YOH-11 (.1 mg/kg/min.), 8/30, 1978
19 19
YOH-12 (.25 mg/kg/min.), 9/8, 1978
19 20
YOH-13 (.25 mg/kg/min.), 9/8, 1978
19 21
YOH-14 (.25 mg/kg/min.), 9/8, 1978
19 22
YOH-15 (.025 mg/kg/min.), 9/18, 1978
19 23
YOH-16 (.025 mg/kg/min.), 9/18, 1978
19 24
YOH-17 (.1 mg/kg/min.), 12/14, 1978
19 25
YOH-18 (.1 mg/kg/min.), 12/14, 1978
19 26
YOH-19 (.05 mg/kg/min.), 12/15, 1978
19 27
YOH-20 (.05 mg/kg/min.), 12/15, 1978
19 28
YOH-21 (.05 mg/kg/min.), 12/18, 1978
19 29
YOH-22 (.05 mg/kg/min.), 12/18, 1978
19 30
YOH-23 (.05 mg/kg/min.), 12/19, 1978
19 31
YOH-24 (.0025 mg/kg/min.), 12/20, 1978
19 32
YOH-25 (.025 mg/kg/min.), 12/20, 1978
19 33
YOH-26 (.025 mg/kg/min.), 12/20, 1978
19 34
YOH-27 (.0025 mg/kg/min.), 12/21, 1978
19 35
YOH-28 (.0025 mg/kg/min.), 12/21, 1978
19 36
YOH-29 (.0025 mg/kg/min.), 12/21, 1978
 
Other experiments, 1952-2003
19 37
1. aging -- CBF -- Normal, 1955-1957
19 38
2. aging -- CBF -- hypertension, 1956
19 39
3. aging -- CBF -- arteriosclerosis, 1956-1957
19 40
4. aging -- CBF -- chronic brain syndrome, 1957-1958
19 41
B. aging -- patient material, 1957-1959
19 42
C. Aging -- Statistics, 1958-1959
19 43
C. Aging -- Statistics, 1959
19 44
D Aging -- Inter Correlations, 1959-1960
19 45
E Aging -- research data, 1959-1960
20 1
ANES series, 1993
20 2
ANES 1-5, Jan. 5-11, 1993
20 3
ANES 6-10, Jan. 12-25,1993
20 4
ANES 11-15, Feb. 1-9, 1993
20 5
ANES 16-20, Feb. 16-23, 1993
20 6
ANES 21-25, March 21-31, 1993
20 7
ANES 26-30, March 9-22, 1993
20 8
ANES31-34, March 23-28, 1993
20 9
ANES, 1992
20 10-11
Arterial curves -- O2 -- C02 series, 1956
20 12-13
Arterial curves -- SCL series [photographs], 1956
20 14
CE-1: lumped constant rat, 5%, CO2 inhal, 1974
20 15
CE-2: lumped constant rat, 5% CO2 inhal., undated
20 16
CE-3: lumped constant rat, 5% CO2 inhal., 1975
20 17
CE-4: lumped constant rat, 5% CO2 inhal., 1975
20 18
CK1, 60 min. normal control, 6/15, 1978
20 19
CK2, 60 min. 6/15, 1978
20 20
CS-23, 7/10, 1978
20 21
CS-24, 8/21, 1978
20 22
CS-26, 12/13, 1978
20 23
CS-27, 12/14, 1978
20 24
G5 Ur W5 V4 original rate constants, undated
20 25
Parameters (V4 V4 G6 W5) pulse experiments -- new 3 rate constants, 1985
20 26
HYP1 (10%), 1/15, 1976
20 27
HYP2 (10%), Jan. 15, 1976
20 28
HYP-3 (7.5% O2), Jan. 21, 1976
20 29
HYP-4 (7.5% O2), Jan. 21, 1976
20 30
Hypoxia 10% O2 behavior: observation, 1976
20 31
LCBF summary, undated
20 32
LCBF summary for misc. data, undated
20 33
Sheet for LCBF, undated
20 34
1 washout constant exp., flow rate: 0.8 ml/min., 1991
20 35
2 washout constant exp., flow rate: 1.0 ml/min., 1991
20 36
03 washout constant exp., flow rate: 1.2 ml/min., 1991
20 37
04 washout constant exp., flow rate: 0.6 ml/min., 1991
20 38
05 washout constant exp., flow rate: 1.4 ml/min., 1991
20 39
06 washout constant exp., flow rate: 1.6 ml/min., 1991
20 40
Washout correction for LCBF equation, undated
20 41-42
Wynn project -- alleged non-mitochondrial thyroxine stimulation of protein synthesis -- Nov. 9, 1970
20 43
2 Deoxyglucose Studies (Rat, Cat), 1973-1983
20 44
2.5 min., undated
20 45
5.0 min., undated
20 46
10 min., undated
20 47
15 min., undated
20 48
30 min., undated
20 49
45 min., undated
20 50
60 min., undated
20 51
90 min., undated
20 52
120 min., undated
20 53
14C Toluen internal std. -- lot 0060283A, 1986
20 54
14c-warfarin, 1993
20 55
Abrams -- lumped constant data, 1985
136 11
Absorption Spectra, undated
20 56
Additional structure morphine, undated
20 57
Alfred Benzon symposium, 1990
20 58
Amanda, 12/5, 1979
20 59
Amersham standard calibration, 1978
20 60
Analytical ultracentrifuge records [photographs], 1966
20 61
Anesthesia record, undated
21 1
Animal phosphate [photographs], 1978
21 2
AP vs. IAP rat summary, undated
21 3
Arithmetic mean value of gray structures (pulse experiments), 1979
21 4
Arterial blood studies (Tbl 1) (from Reivitch, et. al.) [slides], 1977
21 5
Astroglial exp. -- amino acid analysis key, 1995
21 6
Astroglial exp. -- Dr. Kaufman's cell extract samples, 1995
21 7
Astroglial exp. -- intracellular A.A., 1995
21 8
Atlas -- 1, 1980
21 9
Amino-acid-analyzen, 1992
21 10
A. V. blood curves -- desaturation curves studies, 1952-1956
21 11
Banzo (sleep control), 1980
21 12
Basil, 6/13, 1979
21 13
Beckman polygraph calibration, undated
21 14
Blank sheets for experiments, undated
21 15
Crop, 6/25, 1979
21 16
Brain development, undated
21 17
Bonzo, film 21, 1985
21 18
Brain -- (Gelber) photos and negatives [photographs, negatives], 1967
21 19
Calibration of plastic standards, 1969-1975
21 20
Calibration of standards, undated
21 21
Calibration standards using the 10" and "new low" standards", 1986
21 22
Catheter -- calibration exp., 1991-1992
21 23
Catheter smear collection, undated
21 24
Caveness study materials [photographs], undated
21 25
CCK -- vagotomized, 1980
21 26
Chico, 1980-1984
21 27
Chr. Li-1, 5/27, 1980
136 12
Chromatogram Records, 1960
21 28
Chronic -- nitro i.p., 1993
21 29-30
Chronic i.p. of L-NAME series vol. 1-2, 1993
21 31
Clinical trials of barbiturates in rats, 1972
21 32
Collaboration -- Bill Eckelman and Juntendo Univ., 1999
21 33
Collaboration -- Dr. David M. Cohen, 2000-2003
21 34
Collaboration -- Dr. Rolf Gruetter -- Univ. of Minnesota, 1999-2001
21 35
Collaboration -- SuperGen, 1999-2000
21 36
Dee, film 8-35, 1978
21 37
Dee, film no. 7-35, 1979
21 38-39
Densitometric calibration curves, 1953-1955
21 40
Densitometry 1, 1953-1954
21 41
Densitometry 2, 1954
22 1
Deoxyglucose review, 1980-1981
22 2
Directories -- disk and tape, 1985
22 3
Discarded animals, 1972
22 4
Dreamless, film 17, undated
22 5
Dreamless, 1980
22 6
ECF mixed culture (counting data), 1995
22 7
ECG, EOG and EMG (from Reivitch, et. Al.) [Slides], 1985
22 8
Effects of barbiturates on blood gases, undated
22 9
Effects of epinephrine on blood glucose, 1958-1959
136 13
Effects of Thiopental Anesthesia on Local Cerebral Glucose Utilization in the Albino Rat, undated
22 10
Equilibrium, undated
22 11
ER-M, C-31'-236 uc., 1973-1974
22 12
Exp. CC1, 1980
22 13
Exp. CC2, 1980
22 14
Exp. CC5, 1980
22 15
Exp. CR2, 1980
22 16
Exp. CR3, 1980
22 17
Exp. CR4, 1980
22 18
Exp. CR6, 1980
22 19
Exp. CR7, 1980
22 20
Experiment 6: raw data -- nucleotide separation by high voltage electrophoresis, 1970
22 21-22
Factor preparation and properties -- book 2, 1968-1974
22 23
Factor TLC scans, 1969
22 24
Failed experiment, Aug. 22, 1991
136 14
Fasting and Brain Metabolism, 1969-1973
136 15
G. Fitzgerald Experiments, 1971
22 25
G5 U4 with new 3 rate constants -- Ki*=.232, K2*=.240, K3*=0.61, 1985
22 26
GEE -- experiment work sheep, 1978-1979
22 27
GEE file no. 7-33, 1979-1980
22 28
Glucose deter.: Beckman vs. Gilford, 1975
22 29
Glucose deter.: with glass vs. Eppendorf pipets, 1975
22 30
Glucose determination (spectrophotometer), undated
22 31
Glucose determination: glucose oxidase method, undated
22 32
Glucose determination: miscellaneous, 1973-1975
22 33
GU-BMF (multi-film program), undated
22 34
Guide to reading auto radiographs, undated
22 35
Hemoglobinometry, 1979
22 36
HG misc., 1980
22 37
High-std-1, 14c meth. Glucose, 1978
22 38
History: rat thyroidectomies, 1960-1966
22 39
Hydroxybuty rate assay, 1969
22 40
Hyperinsulinemia experiments, 1980
22 41
Info. on micropipettes and pumps, 1973
22 42
Insulin hypoglycemia (50 uci/animal), undated
22 43
Internal standard, 1985
22 44
L.S. brain -- I, 1977
22 45
Laplace transform -- technical info., 1975
22 46
Liquid scintillation media, 1974
22 47
List of research projects planned, undated
22 48
Low standard I graph, 1977
22 49
LSD-DG series, 1975-1976
22 50
M. Shionohara -- summarized date, 1979
22 51
Manuscript -- Dr. Sokoloff [photographs], undated
22 52
Marburg slides, undated
22 53
Mean weighted average (GU) -- square exp. (GU was calculated with weighted average of tissue conce.), 1979
22 54
Mean weighted average of GU (GU was directly calculated by image processor), undated
22 55
Metabolic maturation of the brain in relation to asphyxia neonatorum, 1963-1964
22 56
Milt, 6/14, 1979
22 57
Milt, film no. 1-32, 1979-1982
22 58
Misc. papers, 1979-1980
22 59
Miscellaneous statistical analyses, 1960
22 60
Mixed and astroglial culture, 1995
22 61
Morphine summary, undated
22 62
MTZ-1, Dec. 1, 1975
22 63
MTZ-2, Dec. 2, 1975
22 64
N.E.N. standard calibration, 1978-1979
23 1
NH3 -- 1-3, HF -- 1-2, GD -- 1-3, DLX, DX 1-4 Rats [X- Rays], 1977
23 2
N.O.S. assay, 1992-1993
23 3
Nitro i.p. -- enzyme assay, 1993
23 4
No synthase assay, 1992-1993
23 5
NOD, 3/18, 1980
23 6
Nodoz, 4/8 [photographs], 1980
23 7
Nodoz, film 6, 1980
23 8
NOS activity after nitroarginine intracisternal infusion, 1993
23 9
Nose, 3/22, 1979
23 10
OD vs. con. x time, undated
23 11
Olf. Bulb, undated
23 12
Original 3-rate constants, 1986
23 13
Parameters (pulse experiments ) 5 rate constants (K4*=0.0014), 1986
23 14
Parameters (pulse experiments) -- 5 rate constants (K4*=0.002), 1986
23 15
Parameters (square exp.) 5 rate constants, 1986
23 16
Parsley, 7/10, 1980
136 16
Peroxidase Kinetics -- Model #1, undated
136 17
Peroxidase Kinetics -- Model #2, undated
136 18
Peroxidase Kinetics -- Model #3, undated
23 17
Phosphate, 1979
23 18
Phosphate, 1978
23 19
Physiological conditions' summary -- pulse exp., undated
23 20
Plasma curves, undated
23 21
Poly. fitting -- plastic standards, 1973
23 22
Posh, 8/6, 1980
23 23
Pulse experiments parameters -- 5 rate constants (K4*=0.001), 1986
23 24
Pump schedule sheet, undated
23 25
Puromycin -- originals negatives [negatives], undated
23 26
Psychological vs. Physiological, 1961
23 27
Radiochemical specifications, 1967-1974
23 28
Rat DX-4, 1971
23 29
Rate constant experiments, 1970-1992
23 30
Red-outline drawings, undated
23 31
REM4, awake cont. cat, 1976
23 32
REM5, 1976
23 33
Reproduce Iadecola's experiment, 1992
48 28
Research medicine [experiment proposal], 1992
23 34
Reza, Sept. 10, 1979
23 35
Ribosomal protein -- orig. photos and neg. [photographs, negatives], undated
23 36
Roche system -- originals and photographs [negatives], undated
23 37
Rocky, undated
23 38
Rocky, 10/26, 1978
23 39
Rocky, film no. 1-32, 1979
23 40
Sakurada abstract -- effects of immobilization, 1977
23 41
Salicylates -- illus. and negatives [negatives], undated
136 19
Separation of AMP, ADP, and ATP Using Electrophorisis, 1970-1971
23 42
Series AB: laplace transform, 2 DG. rats: BARB. ANES, 1975
23 43
Series AUD-111: auditory alterations, 1973
23 44
Series AUD-2: auditory alterations, 1974
23 45
Series AUD-3: auditory alterations, 1974
23 46
Series AUD-4: auditory alterations, 1974
23 47
Series CB: laplace transform, 2DG. rats: 5% CO2, 1975
23 48
Series NH: ammonium acetate -- 10 m. moles/kg i.p., 1972
23 49
Series normal: normal values in rats, 1971
23 50
Series R-ER-1 to R-ER-7 -- trial at square wave rats -- conscious, 1974
23 51
Series WB: laplace transform, 2DG rats: conscious, 1975
23 52
Shaky, 12-20-79 [photograph], 1979
23 53
Short counts on Beckman L.S5801, 1985
23 54
Sierra, 1980-1984
23 55
Sleep -- spinal cord, undated
24 1
Sleep (end Kennedy files), 1980
24 2
Sleep 1 (fang), 2/13, 1980
24 3
Sleep study, 1981-1990
24 4
Snooz, Jan. 5, 1980
24 5
Sparky -- myelinated [photographs], 1983
24 6
Spot -- sleeping, 2/12, 1981
24 7
Standard calibration, 1979
24 8
Standard strip calibration from G. Dauth, neurosci., Univ. of Mich., Feb. 9, 1980
24 9
Standards, 1979-1983
24 10
Sugar, 1979
24 11
Sugar, film no. 1-28, 1979
24 12
Summarized data for computer analysis, undated
24 13
Summary of parameters (pulse exp.) (square exp.), undated
24 14
Summary of parameters (square exp), undated
24 15
Summary sheets, 1968-1974
24 16-20
Summary tables and graphs, undated
24 21
T3 Be Vwa time course data for Dr. Greenhouse, undated
24 22
Tent rat training record, 1993
24 23
TSC-1, Nov. 10, 1975
24 24
TSC-2, Dec. 1, 1975
24 25
TSC-3, Dec. 2, 1975
24 26
TSC-4, Dec. 4, 1975
136 20
University of Pennsylvania [Research Notes], 1950-1953
136 21
[Unidentified Research Notes], [circa 1950s]
24 27
Values of rate constants in the normal conscious albino rat, undated
24 28
Visual alteration: enucleation, 1973
24 29
Weighted average concentration -- (pulse experiments) Dr. Shinohara's data, 1986
24 30
Whole blood samples, undated
24 31
Windy, 1978
24 32
Windy [photograph], 1978-1979
24 33
Windy, film no. 7-33, 1978
24 34
Winx, 1985
24 35
Winx (sleep control), 1980
24 36
Winx, film 16, 1987
 
Research Notebooks, 1952-2002 [subseries]:
24 37
A -- 9 5 HTT Mice, 2002
24 38
Aldose reductase, 1989
25 1
Alison's notebook -- Cathy, 1989
25 2
Alison's notebook -- C-fox S-S rats, 1989-1990
25 3
Alison's notebook -- hematology plates (property of J. D. Brown HMI), 1956
25 4
Alison's notebook -- HRP ganglion and stimulation [photograph], 1982
25 5
Alison's notebook -- hypothyroid rats, 1979-1980
25 6
Alison's notebook -- ICSS surgery, 1981-1989
25 7-8
Alison's notebook -- ICSS testing book, 1984-1987
25 9
Alison's notebook -- Lida's baby rats, 1982
25 10
Alison's notebook -- LSU series, autoradiography and histology, 1986
25 11
Alison's notebook -- MFB rats, 1989
25 12
Alison's notebook -- new protocol for temp. experiments, undated
25 13
Alison's notebook -- papers/protocols, 1989-1990
25 14
Alison's notebook -- rats, 1988
25 15
Alison's notebook -- temp. experiments, 1987
25 16
Alison's notebook -- water rats, undated
25 17
Animal record book, 1958-1960
25 18
Annual report -- laboratory of clinical science, 1962-1963
25 19
Assays, enzymes and preparations, 1958-1966
25 20
Autoradiography, 1976-1977
25 21
Autoradiography, 1979
26 1
Autoradiography, 1994-1996
26 2
Autoradiography book I and book II, 1978
26 3
Bay K 8644, 2000
26 4
Blood oxygen book I, 1954-1957
26 5
Bilateral CBF St. Elizabeth's, 1962-1964
26 6
Brain G-6pase rate constants K4K5, 1990-1993
26 7
CY Bay K continuous Infusion (wisker 2D G), 2001
26 8
Dr. Kennedy and Alison -- perfused 2 DG animals, 1979
26 9
Durell, 1954
26 10
Elaine Kaufman notebook: book 1 -- enzyme purification, 1986-1987
26 11
Elaine Kaufman notebook: book 2 -- enzyme purification, 1987-1988
26 12
E. Kaufman notebook: GLIA -- I, 1986-1988
26 13
E. Kaufman notebook: GHB dehydrogenase II, 1982
26 14
GLIA 4, 1993-1994
26 15
E. Kaufman notebook: GLIA -- book 5, 1995
26 16
E. Kaufman notebook: GLIA -- neurons, book 6, 1996-1997
27 1
Elaine Kaufman notebook: GLIA -- neurons (book -- 7), 1998-1999
27 2
E. Kaufman Notebook: Book IX, 1971-1972
27 3
E. Kaufman notebook: survey book, 1972-1981
27 4
Elaine Kaufman notebook -- GHB enzyme in GLIA and neurons, 1988
27 5
Elaine Kaufman notebook: GHB, 1984-1985
27 6
Elaine Kaufman notebook: GHB clinical studies, 1984-1985
27 7
Elaine Kaufman notebook: GHB-C-AMP, book I, 1991-1992
27 8
Elaine Kaufman notebook: GHB degradation II, 1985-1986
27 9
Elaine Kaufman notebook: GHB degradation III, 1986-1989
27 10
Example of experimental protocols -- factor method -- Patricia A. Roberts, 1966-1968
27 11
GHB-C-AMP, book II, 1992-1994
27 12
GB- 19 -GB22 -- HLI -- HL25 -- GB25 -- GB30, 1999
27 13
GB31 -- 52 -- GM1 -- 20, 2000
27 14
GHB biosynth. -- B40, 1986-1993
27 15
GHB-Dehydrogenase preparation, 1979-1980
28 1
Glucose, 1957-1959
28 2
Glucose determination, 1955-1957
28 3
Haloperidol (HX) -- Glibenclamide (GB), 1999
28 4
IAP book I, undated
28 5
Instruments, 1952-1957
28 6
J.D., 1952-1955
28 7-17
Jane Pietrosewicz -- autoradiography books, 1980-1992
29 1-3
Jane Pietrosewicz -- autoradiography books, 1993, 1996-2002
29 4
K- Channel Opener, undated
29 5
L. Libow data, 1961
29 6
Large scale assay, 1967-1969
29 7
Micro analysis of Iodine in Tissues, 1955
29 8
Miscellaneous experiments, 1959-1968
29 9
Miscellaneous preparation, assays, 1969
29 10
Miscellaneous Warburg experiments, 1956-1958
29 11
ND 28-31 CK 15-, 2002
29 12
Nifedipine, 2001
29 13
Nimodipine (ND) -- Ibenotoxin (CK), 2001
29 14
Nitrogen determination -- book I, 1958-1962
29 15
Nitrogen determination -- book 2, 1962-1967
29 16
Nitrogen determination -- book III, 1967
29 17
Note book -- Jane Jehle, 1964-1975
29 18
Organic synthesis -- book I, 1959
29 19
Oxidative phosphorylation -- book 2, 1958
29 20
Personal solutions 1, 1970-1972
30 1
PH., 1956-1958
30 2
Phosphate determinations -- book 1, 1962-1969
30 3
Phosphate determinations -- book II, 1969
30 4
Preparations of ribosomes -- book 1, 1963-1966
30 5
Preparations of SRNA amino acid -- book IA, B, and C, 1961
30 6
Preparations of SRNA amino acids -- book II-C, 1961-1964
30 7
Preparations of SRNA amino acids -- book III-C, 1965
30 8
Protein determinations -- Biuret method, 1971
30 9
Protein determinations -- Kjeldahl method, 1963-1964
30 10
Protein determinations: Lowry method -- book 1, 1963-1967
30 11
Protein determinations: Lowry method -- book 2, 1967-1971
30 12
Protein determinations: Lowry method -- book 3, 1972
30 13
Pyruvate carobxylase in brain -- GLIA II, 1988-1989
30 14
R. Neill, 1973
30 15-20
Research notebook -- book 1-6, 1970-1972
31 1-14
Research notebook -- book 4-17, 1958-1963
32 1
Research notebook -- book 18, 1963
32 2
Research notebook -- book 19F, 1964-1965
32 3
Research notebook -- book 19M, 1964-1966
32 4-9
Research notebook -- book 20F-25F, 1965-1969
32 10
Research notebook -- book 1BR, 1960-1970
32 11-14
Research notebook -- book 2T-5T, 1964-1966
33 1-7
Research notebook -- book 6T-12T, 1966-1967
33 8-12
Research notebook -- book 7-11, 1972-1973
33 13
Research notebook -- book IIA, 1961
33 14
Research notebook -- book IIB, 1961-1962
33 15
Research notebook -- book IIIA, 1962-1963
33 16
Research notebook -- radioactive phosphate and adensive nucleotide experiment, 1960-1965
33 17
Research notebook -- salicylate effects on amino acid incorporation (SEOAAI) -- book 1, 1966
33 18-22
Research notebook (SEOAAI) -- book 2-6, 1966-1967
33 23
RLK solutions I, 1964-1966
34 1-2
RNA determinations -- book 1 and 2, 1963-1967
34 3
Salicylate, 1966
34 4
Section on cerebral metabolism, 1954-1958
34 5
Section on cerebral metabolism -- sample wts. for radioactive assay PH, 1956-1958
34 6
Section on cerebral metabolism -- 26F, 1970
34 7
Section on cerebral metabolism -- 27F, 1970-1974
34 8
Section on cerebral metabolism -- book 1, 1958-1959
34 9
Section on cerebral metabolism -- EP + Nor EP -- book 1, undated
34 10
Sleep, 1966
34 11-12
Solutions -- B. A. Jant Franke, 1966-1973
34 13
Solutions -- B38, 1985-1994
34 14-16
Solutions -- book I, 1956-1965
34 17
Solutions IV, 1965-1966
34 18
Solutions VI, 1973-1976
34 19
Solutions -- local protein synthesis, 1982
34 20
Solutions, T. Nelson, 1975-1984
35 1
Specifications and criteria for biochemical compounds, 1960
35 2
Spectophotometry, 1954-1958
35 3
Spectrophotometry 2 -- 02 saturation blood, 1957-1958
35 4-5
Sydell Gelber, 1959-1960
35 6
Synthesis of monoiodohistidine, 1968
35 7
The effect of thyroid hormone on purified kinase enzymes -- book I, 1967
35 8
Thyroid Mice Study, 2001
35 9
Thyroid solutions, 1966-1967
35 10
Van Slyke analyses, 1955-1956
35 11
Van Slyke manometer -- book I, 1954-1956
35 12
Van Slyke manometer -- book III, 1955-1956
35 13
Van Slyke -- Gladys Ellis -- book IV, 1956-1958
35 14
Van Slyke data -- book V, 1956-1958
35 15
Van Slyke -- book VI, 1958
35 16
Warburg calibration -- standard solutions, 1957-1959
35 17
Warburg experiments -- book 1, 1955-1957
 
Research Data PET Scans, 1953-2002, undated [subseries]:
 
Numbered, 1981, undated
50 1
1 autoradiograph with standard [photographs, negative], undated
50 2
2 DG + DG2 + MG molecules [photographs, negative], undated
50 3
3 DG through brain barrier [photographs, negative], undated
50 4
4 functional anatomy of operational -- *DG equ. [photographs, negative], undated
50 5
5 lumped constant in several species [photographs, negative], undated
50 6
6 glucose utilization in conscious rat and monkey [photographs, negative], undated
50 7
7 effects of thiopental anesthesia on cerebral glucose utilization [photographs, negative], undated
50 8
8 spinal cord effects of unilateral stimulation [photographs, negative], undated
50 9
9 relationship between frequency of stimulation and LGU [photographs, negatives, slides], undated
50 10
10 focal seizure during LGU [photographs, negatives], undated
50 11
11 otitis [photographs, negatives], undated
50 12
12 left eye removed (rat) L.G.U. [photographs, negatives], undated
50 13
13 coronal brain (monkey) [photographs, negatives], undated
50 14
14 coronal brain (monkey) -- rt. eye occluded, undated
50 15
15 [negative], undated
50 16
16 12 hr. lt./12 hr. dk. (glucose utilization) [photographs, negative], undated
50 17
17 apomorphine rt. eye enucleated [photographs, negative], undated
50 18
18 effects of d- and 1- amphetamine on LCGU in rat [photographs, negative], undated
50 19
19 computer diagram image display system [photographs, negative], undated
50 20
20 average brain cerebral glucose utilization [negative], undated
50 21
21 ageing and metabolism [photographs, negative], undated
50 22
22 ageing and metabolism [photographs, negative], undated
50 23
23 ageing and metabolism, LCGU vs. apomorphine [photographs, negative], undated
50 24
24 ageing, LCGU vs. apomorphine [photographs, negative], undated
50 25
25 LCGU vs. aopmorphine (subthalamic nucleus and inferior olivary nucleus) [photographs, negative], undated
50 26
26 LCGU vs. apomorphine (ageing) [photographs, negative], undated
50 27
27 DG, FDG, CH3 -- glucose, brain pictures [photographs, negative], undated
50 28
28 glucose metabolic rate (FDG) [photographs, negative], undated
50 29
29 LCGU vs. apomorphine (age), undated
50 30
30 LCBF w/[I125] Hipdm vs. [C14} idoantipyrine [photographs, negative], undated
50 31
31 LCBF indicator fraction method [photographs, negative], undated
50 32
32 spreading depression [photographs, negative], undated
50 33
33 [photographs, negative], undated
50 34
34 electrical stimulation and DG* uptake in pituitary [negative], undated
50 35
35 socium pump and neurosecretion effects on DG* uptake [photographs, negative], undated
50 36
36 [125] hipdm and products vs. radioactivity in arterial blood [photographs, negative], undated
50 37
37 radioactivity DPM vs. time curves [photographs, negative], undated
50 38
38 spreading cortical depression (KCI) [photographs, negative], 1981
50 39
39 osmotic opening of BBB [photographs, negative], undated
50 40
40 blood flow vs. LGU in conscious and anesthetized [photographs, negative], undated
50 41
41 [photographs, negative], undated
50 42
42 glucose utilization in dark-adapted rats (saline vs. apomorphine) [photographs, negative], undated
50 43
43 dark-adapted rats (eye enucleated) saline vs. apomorphine [photographs, negative], undated
50 44
44 effects of light intensity on LGU [photographs, negative], undated
50 45
45 [125I] hipdm single pass extraction vs. venous [photographs, negative], undated
50 46
46 deosyglucose vs. glucose in arterial and venous [photographs, negative], undated
50 47-48
47 influence of rate constants on integrated pool specific activity [photographs, negative], undated
50 49
48 rate constants in the normal conscious albino rat [negative], undated
50 50
49 lump constant vs. time [photographs, negative], undated
50 51
50 cerebral metabolism of [14C] DG and G in vivo [photographs, negative], undated
50 52
51 blood CO2 curves [photographs, negative], undated
50 53
52 striate cortex (monkey) [photographs, negative], undated
50 54
53 autoradiograph dorsolateral surface of monkey occipital lobe [photographs, negative], undated
50 55
54 LCGU vs. apomorphine [photograph, negative, slides], undated
50 56
55 systems involved in higher functions [negative], undated
50 57
56 auditory system (LCGU) [negative], undated
50 58
57 auxtomy, leucine protein synthesis [photographs, negative], undated
50 59
58 auxtomy, DG, protein synthesis nissl stain [photographs, negative], undated
50 60
59 3H and 24C DG [photographs, negative], undated
50 61
60 brain anatomy labeled [photographs, negative], undated
50 62
61 experimental period effects on gray matter glucose utilization [photographs, negative], undated
50 63
62 visual stimulus (3H] DG [photographs, negative], undated
50 64
63 pretectal nucleus [photographs, negative], undated
50 65
64 visual cortex [photographs, negative], undated
50 66
65 lateral geniculate nucleus [photographs, negative], undated
50 67
66 posterolateral nucleus of the thalamus [photographs, negative], undated
50 68
67 blood flow vs. LCGU (control) [photographs, negative], undated
50 69
68 blood flow vs. LCGU (acidosis) [photographs, negative], undated
50 70
69 blood flow vs. LCGU (acidosis and control) [photographs, negative], undated
50 71
70 antidromic stimulation of superior cervical ganglion [photographs, negative], undated
50 72
71 superior colliculus LCGU vs. light intensity [photographs, negative], undated
50 73
72 *DG and *DG-6-phosphate concentration over time [photographs, negative], undated
50 74
73 antidomic stimulation of superior cervical ganglion [photographs, negative], undated
50 75
74 antidromic stimulation of superior cervical ganglion [photographs, negative], undated
50 76
75 air embolism and control in K+ concentration [photographs, negative], undated
50 77
76 air embolism and control in pH of injection fluid [photographs, negative], undated
50 78
78 post axotomy and control [photographs, negative], undated
50 79
80 [photographs, negative], undated
50 80
81 hypoxemia [photographs, negative], undated
50 81
82 darkness vs. 700 lux (pigmented rats) [photographs, negative], undated
50 82
83 hypoxemia [photographs, negative], undated
50 83
84 hypoxemia [photographs, negative], undated
50 84
85 darkness vs. 700 lux (albino rats) [photographs, negative], undated
50 85
86 newborn monkey [photographs, negative], undated
50 86
87 [photographs, negative], undated
50 87
88 spinal cord [photographs, negative], undated
50 88
89 globus pallidus, etc. [negative], undated
50 89
90 reginal glucose utilization [photographs, negative], undated
50 90
91 reginal glucose metabolism after 10 min. cerebral ischemia in the rat [photographs, negative], undated
50 91
92 [photograph], undated
50 92
93 left eye removed [photographs, negative], undated
50 93
94 penn. seizure antipyrine, baby monkey [photographs, negative], undated
50 94
95 effects of thiopental anesthesia on cerebral glucose utilization [photograph], undated
50 95
97 equilibration of glucose specific activity between plasma and brain [photographs, negative], undated
50 96
98 influence of duration on glucose utilization [photographs, negative], undated
50 97
99 relationship between stimulation and L.G.U. [photographs, negative], undated
50 98
100 determination of glucose specific activity [photographs, negative], undated
50 99
101 brain-plasma glucose equilibration, undated
50 100
102 tissue glucose pool 1/2 life vs. plasma glucose concentration [photographs, negative], undated
50 101
103 glucose activity in plasma, tissue [negative], undated
50 102
104 cerebral 02 consumption in cerebral blood flow [photographs, negative], undated
50 103
105 half-lives of DG*-6-P in grey and white matter [photographs, negative], undated
50 104
106 arterial and venous [ ] of 14c D.G. following i.v. in a cat [photographs, negative], undated
50 105
107 derivation of operational method for measurement of LCGU [photographs, negative], undated
50 106
108 tissue pool 1/2 life [photographs, negative], undated
50 107
109 math. analysis of model for total accumulation of DG* and DG*-P [photograph, negative], undated
50 108
110 theoretical calculation of [14c] DG-6-P in rat brain [photographs], undated
50 109
111 general equation + influence of phosphotase activity [photograph, negative], undated
50 110
112 lumped constant calculation used by Hawkins and Miller [photographs], undated
50 111
113 [photograph], undated
50 112
114 equation for changing plasma glucose concentration [photograph, negative], undated
50 113
115 BBB model and equation of 14C glucose uptake [photograph, negative], undated
50 114
116 glucose uptake model + equation [photographs, negative], undated
50 115
117 LCGU in conscious albino and pigmented rats [negative], undated
50 116
118 glucose utilization in sensorimotor systems [negative], undated
50 117
119 glucose utilization in myelinated fiber tracts [negative], undated
50 118
120 glucose utilization in limbic system [negative], undated
50 119
121 glucose utilization in conscious and restrained rats [negative], undated
50 120
122 glucose utilization of the visual system [negative], undated
50 121
123 1/2 life of tissue pool in male rats [negative], undated
50 122
124 turnover of tissue glucose pool in male rats [negative], undated
50 123
125 values of rate constants in normal conscious albino rats [photographs, negative], undated
50 124
127 conditions w/altered function in CNS w/out change in average body metabolism [photograph], undated
50 125
128 relationship between consciousness and cerebral metabolic rate [photograph], undated
50 126
129 sodium pump and neurosecretion effects on DG* uptake, undated
50 127
130 functional anatomy of the DG*method equ. [photographs, negative, slide], undated
50 128
131 operational equation of [14C] DG method [photographs, negatives], undated
50 129
132 plasm -- tissue B-B-B (revised by Smith) [photographs, negatives], undated
50 130
135 LCBF with hipdm indicator fractionation method [photographs, negatives], undated
50 131
136 [14c] glucose-6-P single pass extraction fraction [photographs, negatives], undated
50 132
137 LCBF w/[I125] hipdm tissue equilibration method [photographs, negatives], undated
50 133
138 retinal stimulation in rats [photographs, negatives], undated
50 134
139 local cerebral glucose utilization [photographs, negatives], undated
50 135
140 local cerebral blood flow [photographs, negatives], undated
50 136
141 kinetics of competitive substrate reactions [photographs, negatives], undated
50 137
142 CBF and CMR 02 vs. years [photographs, negatives], undated
50 138
143 influence of CO2 in correlation between LCBF and LCGU [photographs, negatives], undated
50 139
144 monkey [photographs, negatives], undated
50 140
145 glucose utilization vs. stimulation frequency [photographs, negatives], undated
50 141
146 operational equation of [14C] deoxyglucose method [photograph], undated
50 142
147 cervical ganglion drawing [photographs, negatives], undated
51 1
148 cervical ganglion drawing [photographs, negatives], undated
51 2
149 cervical ganglion (micro) [photographs, negatives], undated
51 3
150 effects of apomorphine upon glucose utilization in habenula [photographs, negatives], undated
51 4
151 LCGU vs. halperidol [photographs, negatives], undated
51 5
152 LCGU vs. apomorphine [photographs, negatives], undated
51 6
153 preanglionic holinergic fibers [photographs, negatives], undated
51 7
154 pre-ganglionic cholinergic [photographs, negatives], undated
51 8
155 focal seizures -- protein synthesis [photographs, negatives], undated
51 9
156 focal seizures (metabolic effects) [photographs, negatives], undated
51 10
157 optical density, apomorphine vs. halperidol [photographs, negatives], undated
51 11
158 apomorphine vs. haloperidol (magnification) [photographs, negatives], undated
51 12
159 slide to side differences in monkey brain structures [photographs, negatives], undated
51 13
160 LGU in monkey brain [photographs, negatives], undated
51 14
161 influence of age on responsiveness to apomorphine [photographs, negatives], undated
51 15
162 influence of age on responsiveness to apomorphine (zona compacta) [photographs, negatives], undated
51 16
163 influence of age on responsiveness to apomorphine (aged 48-67) [photographs, negatives], undated
51 17
164 cervical ganglion [photographs, negatives], undated
51 18
165 regional glucose utilization [photographs, negatives], undated
51 19
166 regional glucose utilization (ketamine) [photographs, negatives], undated
51 20
167 regional glucose utilization (limbic system) [photographs, negatives], undated
51 21
168 regional glucose utilization: auditory, visual, sensory [photographs, negatives], undated
51 22
169 physiologic pearmeters [photographs, negatives], undated
51 23
170 LCGU (percentage change from control) [photographs, negatives], undated
51 24
171 LCGU (percentage change from control) ketamine [photographs, negatives], undated
51 25
172 blood flow transport and metabolism [photographs, negatives], undated
51 26
173 SSA vs. 1/[GHB] [photographs, negatives], undated
51 27
174 SSA or NADPH vs. 1/[NADP+] [photographs, negatives], undated
51 28
175 SSA or NADPH vs. time [photographs, negatives], undated
51 29
176 1/[GHB] vs NADPH, NADPH vs. 1/[NADPH] [photographs, negatives], undated
51 30
177 NADPH vs. 1/[NADPH] and 1/[GHD] [photographs, negatives], undated
51 31
178 SA vs. [GHB] and [D-glucuronate] [photographs, negatives], undated
51 32
179 apomorphine substantia nigra young vs. aged rats [photographs, negatives], undated
51 33
180 monocular deprivation (neonatal monkey) [photographs, negatives], undated
51 34
181 naftidro furyl [photographs, negatives], undated
51 35
182 hypoxemia metabolic raes [photographs, negatives], undated
51 36
183 lateral genic (monkey) [photographs, negatives], undated
51 37
184 ketamine [photographs, negatives], undated
51 38
185 norepinephrine vs. LCGU [photographs, negatives], undated
51 39
186 norepinephrine vs. control LCGU [photographs, negatives], undated
51 40
187 LCGU in white matter during hypoxemia [photographs, negatives], undated
51 41
188 awake/asleep, striate cortex and sensory-motor cortex [photographs, negatives], undated
51 42
189 lumped constant vs. plasma glucose [photographs, negatives], undated
51 43
190 superior cervical ganglia/glucose utilization [photographs, negatives], undated
51 44
191 coeliac and cardiac ganglia/glucose utilization [photographs, negatives], undated
51 45
192 hexokinase synthesis chart [photographs, negatives], undated
51 46
193 physiological variables in hypoxemia [photographs, negatives], undated
51 47
194 average rate of G.U. in whole brain during hypoxemia [photographs, negatives], undated
51 48
195 captopril effects on G. U. of subfornical organ in Brattleboro rats [photographs, negatives], undated
51 49
196 deoxyglucose autoradiographs of cat lumbar spinal cord [photographs, negatives], undated
51 50
197 lumbar spinal cord + brain autoradiographs and stained [photographs, negatives], undated
51 51
198 hyperglycemia lumped constant [photographs, negatives], undated
51 52
199 time course of arterial and venous concentrations of DG* and G [photographs, negatives], undated
51 53
200 model for behavior of leucine in brain [photographs, negatives], undated
51 54
201 glucose clamp [photographs, negatives], undated
51 55
202 lumped constant at different plasma glucose levels, undated
51 56
203 conversion of leucine to acetoacetic acid and acetyl-coenzyme A [photographs, negatives], undated
51 57
204 metabolic rates during hypoxemia [photographs, negatives], undated
51 58
205 axotomy hypoglossal nucleus [photographs, negatives], undated
51 59
206 derivation of operational equ.-model I [photographs, negatives], undated
51 60
207 behavior of leucine in brain model [photographs, negatives], undated
51 61
208 differential equations leucine [photographs, negatives], undated
51 62
209 behavior of leucine in brain model 2 [photographs, negatives], undated
51 63
210 differential equations leucine II [photographs, negatives], undated
51 64
211 derivation of operational equ. -- model III [photographs, negatives], undated
51 65
212 leucine brain -- model III [photographs, negatives], undated
51 66
213 differential equations model III [photographs, negatives], undated
51 67
214 derivation of operational equ. model III [photographs, negatives], undated
51 68
215 derivation of operational equ. III continued [photographs, negatives], undated
51 69
216 derivation of equation [photographs, negatives], undated
51 70
217 model IV -- amino acid incorporation into protein [photographs, negatives], undated
51 71
218 derivation of operational equ. model IV [photographs, negatives], undated
51 72
219 derivation of operational equ. -- model IV continued [photographs, negatives], undated
51 73
220 lumped constant in hypoglycemia [photographs, negatives], undated
51 74
221 DG model -- intracellular and extracellular spaces [photographs, negatives], undated
51 75
222 LCGU kates of insulin-induced hypoglycemia rats [photographs, negatives], undated
51 76
224 physiological variables during insulin-induced hypoglycemia [photographs, negatives], undated
51 77
225 determination of the 1/2 life of the precursor leucine pool [photographs, negatives], undated
51 78
226 synthesis and catabolism of histamine, undated
51 79
227 determination of activity of L-leucine and TRNA-bound leucine [photographs, negatives], undated
51 80
228 scheme for oxidation of [ ]-yydroxybutyrate/ reduction of D-glucuranate [photographs, negative], undated
51 81
229 superior cervical ganglia (G.U. vs. time) [photographs, negative], undated
51 82
230 synaptic mechanisms for histamine neurons [photographs, negative], undated
51 83
231 visual cortex of monkey [photographs], undated
51 84
232 fetal sheep [photographs, negative], undated
51 85
233 fetal sheep? [photographs, negative], undated
51 86
234 saphenous nerve stimulation during anesthesia [photographs, negative], undated
51 87
235 monkey columns [photographs, negative], undated
51 88
236 norepinephrine vs. control LCGU [photographs, negative], undated
51 89
237 autradiographic resolutions [photographs, negative], undated
51 90
239 layer thickness 3H activity [photographs, negative], undated
51 91
240 LandR hemisphere [photographs, negative], undated
51 92
241 functional anatomy of the operational equ. of the 14c DG method [photographs, negative], undated
51 93
242 [photographs, negative], undated
51 94
243 [photographs, negative], undated
51 95
244 [photographs, negative], undated
51 96
245 olfactory bulbs [photographs, negative], undated
51 97
246 relative optical density [photographs, negative], undated
51 98
247 hot hole plug [photographs, negative], undated
51 99
248 brain standards 3H and 14c [photographs, negative], undated
51 100
249 goldfish retinas [photographs, negative], undated
51 101
250 somata cells labeled and unlabeled [photographs, negative], undated
51 102
251 cat muscle, 24c DG [photographs, negative], undated
51 103
252 3H DG water solution frozen in plasma [photographs, negative], undated
51 104
253 grain density in buccal ganglion [photographs, negative], undated
51 105
254 olfactory bulb in tiger salamander 3HDG [photographs, negative], undated
51 106
255 3HDG -- optic lobes of dorsophila melanogaster [photographs, negative], undated
51 107
256 relationship of aggression to onset of lidocaine seizures [photographs, negative], undated
51 108
257 autoradiographic calibration curves vs 3H concentration [photographs, negative], undated
51 109
258 [photographs, negative], undated
51 110
259 occular dominance newborn [photographs, negative], undated
51 111
260 position-emitting atom [photographs, negative], undated
51 112
261 [14C] and [3H] methylglucose [photographs, negative], undated
51 113
262 mid and posterior hypothalamus [photographs, negative], undated
51 114
263 anterior hypothalamus [photographs, negative], undated
51 115
264 dopamine pathways [photographs, negative], undated
51 116
265 integrated tissue specific activity [photographs, negative], undated
51 117
266 energy metabolism in the hypothalamus: effects of reproductive hormones [photographs, negative], undated
51 118
267 integrated tissue sp. ac. [photographs, negative], undated
51 119
268 integrated tissue sp. ac. [photographs, negative], undated
51 120
269 integrated tissue sp. ac. [photographs, negative], undated
51 121
270 GHB-dehydrogenase [photographs, negative], undated
51 122
271 GHB-dehydrogenase [photographs, negative], undated
51 123
272 GHB-dehydrogenase [photographs, negative], undated
51 124
273 GHB-dehydrogenase [photographs, negative], undated
51 125
274 GHB-dehydrogenase [photographs, negative], undated
51 126
275 ESN and WFN, Italy (Smith) [negatives], undated
51 127
276 columns in striate cortex (monkey) [photographs, negatives], undated
51 128
278 computer -- block diagram, undated
51 129
279 hypoxic rat injected with black microspheres, undated
51 130
280 dopaminerglic systems influence [photographs, negative], undated
51 131
281 apomorphine vs. saline on LGU [photographs, negative], undated
51 132
282 ocular dominance columns in monkey [photographs, negative], undated
51 133
283 effects of slow-wave sleep on LGU [photographs, negative], undated
51 134
284 subfornical organ in Battleboro [photographs, negative], undated
51 135
285 neural lobe LGU [photographs, negative], undated
51 136
286 two compartment model for the behavior of leucine brain -- model V [photographs, negative], undated
51 137
287 model VI for behavior of L-leucine in brain [photographs, negative], undated
51 138
288 GHB and GABA levels in rat brain [photographs, negative], undated
51 139
289 cytosol -- rat [photographs, negative], undated
51 140
290 GHB levels -- rat kidney [photographs, negative], undated
51 141
291 GHB dehydrogenase activity in rat kidney [photographs, negative], undated
51 142
292 GHB -- dehydrogenase activity in rat brain [photographs, negative], undated
51 143
293 apomorphine effect on different areas [photographs, negative], undated
51 144
294 superior cervical ganglion -- frequency [photographs, negative], undated
51 145
295 lump constant theoretical derivations [photographs, negative], undated
51 146
296 comparison -- LGU with 3H DG and 14C DG [photographs, negative], undated
51 147
298 bar test after morphine [photographs, negative], undated
51 148
299 morphine effect on LGU in brain [photographs, negative], undated
51 149
300 morphine effect on LGU in brain [photographs, negative], undated
51 150
301 fetal sheep [photographs, negative], undated
51 151
302 fetal sheep [photographs, negative], undated
51 152
303 morphine vs. control tail flick [photographs, negative], undated
51 153
304 average rate of GU for entire brain of fetal and newborn sheep, undated
51 154
305 chemical analysis of 14C DG and 14C DG-L-P in normal rats [photographs, negative], undated
51 155
306 extinction -- Icss [photographs, negative], undated
51 156
307 PCO2 and LCGU relationship [photographs, negative], undated
51 157
308 habenula afferent and efferent pathways [photographs, negative], undated
51 158
309 LGU in laboratory animals [photographs, negative], undated
51 159
310 time course of 14C DG and 14C DG-6-P [photographs, negative], undated
51 160
311 LGU and arterial PCO2 relationship [photographs, negative], undated
51 161
312 habenula and mammillary baby pathways [photographs, negative], undated
51 162
313 lateral habenula and mammillary baby pathways [photographs, negative], undated
51 163
314 [14C] deoxyglucose autoradiographs of cat brains [photographs, negative], undated
51 164
315 effect of acute morphine on GU in rat brain [photographs, negative], undated
51 165
315 effect of acute morphine on GU in rat brain [photographs, negative], undated
51 166
316 fetal sheep [photographs], undated
51 167
317 picture procedure, DG method [photographs, negative], undated
51 168
318 axotomy in hypoglossal nucleus [photographs, negative], undated
51 169
319 axotomy -- tongue functions [photographs, negative], undated
51 170
320 age-blood flow and 02 consumption [photographs, negative], undated
51 171
321 exchange of methylglucose between plasma and brain tissue [photographs, negative], undated
51 172
322 data analysis -- ipsilateral vs. contralateral [photographs, negative], undated
51 173
323 LGU stimulation pathway [photographs, negative], undated
51 174
324 3H standards calibration curves [photographs, negative], undated
51 175
325 visual deprivation protein synthesis [photographs, negative], undated
52 1
326 autoradiograph protein synthesis [photographs, negative], undated
52 2
327 LGU other connections [photographs, negative], undated
52 3
328 LGU: sensory-motor systems [photographs, negative], undated
52 4
329 LGU: forebrain terminal areas [photographs, negative], undated
52 5
330 electrode placements: contingent and non-contingent [photographs, negative], undated
52 6
331 electrode placements: stimulated and non-stimulated [photographs, negative], undated
52 7
332 3H methylglucose vs. 14C methylglucose [photographs, negative], undated
52 8
333 3H DG vs. 14C DG [photographs, negative], undated
52 9
334 morphine bar test and tail flick [photographs, negative], undated
52 10
335 [photographs, negative], undated
52 11
336 pineal body -- LGU monkey [photographs, negative], undated
52 12
337 diazepam -- LGU [photographs, negative], undated
52 13
338 TXW vs. control [photographs, negative], undated
52 14
339 cretin vs. control [photographs, negative], undated
52 15
340 TWX vs. control [photographs, negative], undated
52 16
341 physiological parameters -- day vs. night and sleep vs. awake [photographs, negative], undated
52 17
342 lesion -- lateral habenula -- LGU [photographs, negative], undated
52 18
343 fetal sheep [photographs, negative], undated
52 19
344 LGU in lateral habenula [photographs, negative], undated
52 20
348 GHB -- anaerobic and aerobic [photographs, negative], undated
52 21
349 neural structures regulating fluid balance [photographs, negative], undated
52 22
350 GHB dehydrogenase inhibitors on tissue levels of GHB [photographs, negative], undated
52 23
351 GHB -- synthesis and degradations pathways [photographs, negative], undated
52 24
352 distribution of radioactivity after various stages of fractionation [photographs, negative], undated
52 25
353 distribution of brain glycogen among fractions after extraction [photographs, negative], undated
52 26
354 brain extraction scheme 1 [photographs, negative], undated
52 27
355 brain extraction scheme 2 [photographs, negative], undated
52 28
356 histaminergic sites influence on cerebral vessels [photographs, negative], undated
52 29
357 neurotransmitter substances -- effect on pial arteriolar diameter [photographs, negative], undated
52 30
358 encaphalocoele vs. control, striate cortex of monkey [photographs, negative], undated
52 31
359 insulin -- effect on LGU [photographs, negative], undated
52 32
360 hyperglycemia vs. normal -- LGU [photographs, negative], undated
52 33
361 2-DG-6-PO4 and 2 DG-TLC of brain extracts [photographs, negative], undated
52 34
362 LGU in ganglia during stimulation (H2) in urethane anesthesia [photographs, negative], undated
52 35
363 probe track [photographs, negative], undated
52 36
364 VTA stimulation [photographs, negative], undated
52 37
365 VTA stimulation [photographs, negative], undated
52 38
366 amphetamine -- LGU [photographs, negative], undated
52 39
367 amphetamine -- locomotor and stereotypy scores [photographs, negative], undated
52 40
368 amphetamine [photographs, negative], undated
52 41
369 amphetamine [photographs, negative], undated
52 42
370 amphetamine [photographs, negative], undated
52 43
371 angiotensis II and saralasin [photographs, negative], undated
52 44
372 angiotensinard saralasin [photographs, negative], undated
52 45
373 apomorphine [photographs, negative], undated
52 46
374 apomorphine [photographs, negative], undated
52 47
375 subfornical organ and septal triangular N. -- LGU [photographs, negative], undated
52 48
376 subformical organ and septal tricular N. -- LGU [photographs, negative], undated
52 49
377 sheep LCGU -- pre and postnatal [photographs, negative], undated
52 50
378 caffeine -- LGU [photographs, negative], undated
52 51
379 caffeine -- LGU [photographs, negative], undated
52 52
380 EAS [photographs, negative], undated
52 53
381 female rats during cycle [photographs, negative], undated
52 54
382 electrical stimulation on pineal gland [photographs, negative], undated
52 55
383 female rats during cycle [photographs, negative], undated
52 56
384 model I -- leucine traveling BBB [photographs, negative], undated
52 57
385 percent change of protein synthesis, glucose utilization and relative twitch [photographs, negative], undated
52 58
386 glucose utilization in menstruating rats [photographs, negative], undated
52 59
387 postral calcarin fissure [photographs, negative], undated
52 60
388 optic radiation tract section [photographs, negative], undated
52 61
389 eye occlusion striate cortex [photographs, negative], undated
52 62
390 ambient light markings, striate cortex [photographs, negative], undated
52 63
391 eye occlusion lateral geniculate [photographs, negative], undated
52 64
392 general equ. for measurement of reaction rates with tracers [photographs, negative], undated
52 65
394 [125I] HIPDM and metabolic products in blood [photographs, negative], undated
52 66
395 molecular structure of HIPDM [photographs, negative], undated
52 67
396 [125I] HIPDM single pass extraction [photographs, negative], undated
52 68
397 super optical nucleus, salt loading [photographs, negative], undated
52 69
398 senescence [photographs, negative], undated
52 70
399 maturescence [photographs, negative], undated
52 71
400 LGU % change vs. stimulation frequency [photographs, negative], undated
52 72
401 sciatic nerve stim. LGU in spinal cord and dorsal root ganglia [photographs, negative], undated
52 73
402 water saturated vs. water deprived [photographs, negative], undated
52 74
403 water sated vs. H2O deprived [photographs, negative], undated
52 75
404 water sated vs. H2O deprived [photographs, negative], undated
52 76
405 self-stimulation chapter [photographs, negative], undated
52 77
406 self stim. cocaine/d-amphetamine/morphine [photographs, negative], undated
52 78
407 criteria for adequate psychophysical threshold determination [photographs, negative], undated
52 79
408 self stimulation [photographs, negative], undated
52 80
409 self stim. % response vs. ua [photographs, negative], undated
52 81
410 self stim. X Z score vs. dose [photographs, negative], undated
52 82
411 running speed vs. log pulses per reward [photographs, negative], undated
52 83
412 self-stimulation (graphic) [photographs, negative], undated
52 84
413 response rate vs. intensity (base line drug) [photographs, negative], undated
52 85
414a self stimulation pre/post responses [photographs, negative], undated
52 86
414b acute dehydration [photographs, negative], undated
52 87
415 acute dehydration [photographs, negative], undated
52 88
416 (spinal cord ) acute dehydration [photographs, negative], undated
52 89
417 adrenelectomy and dexamethason [photographs, negative], undated
52 90
418 nerve stimulation -- dorsal root ganglion [photographs, negative], undated
52 91
419 paraventricular nucleus -- acute adrenalectomy [photographs, negative], undated
52 92
420 dehydration [photographs, negative], undated
52 93
421 plasma and brain, deoxyglucose and deoxyglucose -- phosphate [photographs, negative], undated
52 94
422 arterial plasma DG*/G vs. time [photographs, negative], undated
52 95
423 pituitary neural lobe, water sated/water deprived [photographs, negative], undated
52 96
424 septal triangular nucleus [negative], undated
52 97
425 subfornical organ [photographs, negative], undated
52 98
426 latero-lateral habenula [photographs, negative], undated
52 99
427 spinal cord sciatic nerve stimulation [photographs, negative], undated
52 100
428 plasma concentration (arterial and venous) vs. time [photographs, negative], undated
52 101
429 pathways of glucose metabolism [photographs, negative], undated
52 102
430 uptake of [32P] glucose-6-phosphate [photographs, negative], undated
52 103
431 loss of label rates of [2-3H] glucose and [U14C] glucose in brain [photographs, negative], undated
52 104
432 electrical stim. of sciatic nerve on LGU in spinal cord [photographs, negative], undated
52 105
433 fractions of total tissue 14c content in form of free [14c] deoxyglucose in brain [photographs, negative], undated
52 106
434 time courses of [14c] DG and 14c DG-6-P, undated
52 107
435 measured and theoretical time courses of [14c] DG-6-P in brain [photographs, negative], undated
52 108
436 arteriovenous differences of [14c] glucose and [14c] DG [photographs, negative], undated
52 109
437 newborn lamb [photographs, negative], undated
52 110
438 comparative rates of loss of label from 2-[3H] glucose and, undated
52 111
439 nonacidic compounds w/vicinal cis diol. Groups [photographs, negative], undated
52 112
442 effects of fasting on tissue levels of GHB [photographs, negative], undated
52 113
443 biosynthesis of GHB by intact mitochondria [photographs, negative], undated
52 114
444 rates of glucose utilization in rat cervical ganglion [photographs, negative], undated
52 115
445 representative values for LCGU in conscious albino rat and monkey, undated
52 116
446 [photographs, negative], undated
52 117
447 cretin vs. control [photographs, negative], undated
52 118
448 parasaggittal blindspot [photographs, negative], undated
52 119
449 cretin vs. control [photographs, negative], undated
52 120
450 cretin vs. control [photographs, negative], undated
52 121
451 refused monkey cortical section [photographs, negative], undated
52 122
454 E-cat scan of normal brain after injection of [18-F] fluorodeoxyglucose[photographs, negative], undated
52 123
455 [photographs, negative], undated
52 124
456 3H/14C ration in blood glucose [photographs, negative], undated
52 125
457 pathways of GHB metabolism [photographs, negative], undated
52 126
458 LGU in cervical ganglion [photographs, negative], undated
52 127
459 [photographs, negative], undated
52 128
460 simulation effects of frequency on LGU [photographs, negative], undated
52 129
461 effects of acute dehydration on LBG in subfornical organ [photographs, negative], undated
52 130
462 effects of acute dehydration on LGU in paracentricular nucleus [photographs, negative], undated
52 131
463 effects of DD AVP on LGU of septaltriangular nucleus [photographs, negative], undated
52 132
464 effects of DD AVP on LGU of lateral habenula nucleus, subfornical organ and paracentricular nucleus [photographs, negative], undated
52 133
465 Krebs cycle [photographs, negative], undated
52 134
466 Krebs cycles [photographs, negative], undated
52 135
467 metabolism of carbohydrates [photographs, negative], undated
52 136
468 metabolism of carbohydrate w/2-DG and 2-DG-6-P [photographs, negative], undated
52 137
469 [photograph], undated
52 138
470 G-6-P derivative of glucose fraction separated by chromatography [photographs, negative], undated
52 139
471 separation of glucose by column and paper chromatography [photographs, negative], undated
52 140
472 MPTP and L-DOPA [photographs, negative], undated
52 141
473 MPTP and L-DOPA [photographs, negative], undated
52 142
474 Estrus cycle [photographs, negative], undated
52 143
475 dose dependent of methylphoedine [photographs, negative], undated
52 144
476 DPTP and L-DOPA [photographs, negative], undated
52 145
477 G-6-P and DG-6-P activities in rat tissues [photographs, negative], undated
52 146
478 LGU in iodomethacin and dexamethasone [photographs, negative], undated
52 147
479 radiochemical heterogeneity of eluate in Dowex-1-borate column [photographs, negative], undated
52 148
480 theoretical time courses of [14c] DG-6-P in brain [photographs, negative], undated
52 149
481 glucose-6-[32p] phosphate arterial and cerebral venous concentrations [photographs, negative], undated
52 150
482 [14c] G-6-P single pass extraction fraction, undated
52 151
484 time courses of [14C] DG and [14C] DG-6-P [photographs, negative], undated
52 152
485 effects of antidromic stimulation on the rates of glucose utilization [photographs, negative], undated
53 1
486 plasma concentration vs. rate constants [photographs, negative], undated
53 2
487 difference in glucose utilization vs. frequency of stimulation (Hz) [photographs, negative], undated
53 3
488 plasma glucose concentration vs. glucose infusion rate [photographs, negative], undated
53 4
489 lumped constant at different plasma glucose levels [photographs, negative], undated
53 5
490 arterial and venous concentrations [photographs, negative], undated
53 6
491 self stimulation [photographs, negative], undated
53 7
492 self stimulation II [photographs, negative], undated
53 8
493 LGN in intact binocular vision vs. chronic monocular deprivation [photographs, negative], undated
53 9
494 dorsal root ganglion [photographs, negative], undated
53 10
495 monkey arm movement [photographs], undated
53 11
496 estimation of rate constants for dephosphorylation [photographs, negative], undated
53 12
497 LCGU in globus pallidus and subthalmic nucleus [photographs, negative], undated
53 13
498 DG6P by NMR vs. DG6P [GC-MS] [photographs, negative], undated
53 14
499 LCGU in sensorimotor cortex and ventromedial thalamus [photographs, negative], undated
53 15
500 LCGU [photographs, negative], undated
53 16
501 % change in G.U. from no stimulation control values [photographs, negative], undated
53 17
502 % change in G.U. from no stimulation control values [photographs, negative], undated
53 18
503 % change in GU (IPSI vs. contralateral) [photographs, negative], undated
53 19
504 LCGU in medial prefrontal and anterior cingulated cortex [photographs, negative], undated
53 20
505 % change in GU, anterior cingulated and dorsomedial caudate [photographs, negative], undated
53 21
506 changes in metabolic activity during self-stimulation [photographs, negative], undated
53 22
507 behaviors associated w/self-stimulation to the ventral mid brain [photographs, negative], undated
53 23
508 concentrations of glucose, glycogen and lactate [photographs, negative], undated
53 24
509 [14c] DG concentration in plasma, gray and white [photographs, negative], undated
53 25
510 % of 14c as 14c-DG/amount of 14c-DGP found after single injection [photographs, negative], undated
53 26
511 principle of the assay of glucose-6-P in vivo by selective detritiation of [2-3H]G [photographs, negative], undated
53 27
512 incorporation of 2-[14c] deoxyglucose into glycogen a [photographs, negative], undated
53 28
513 GU in control post-radiation: 4 days and 4 weeks [photographs, slides], undated
53 29
514 glucose infusion rate[photographs, negative], undated
53 30
515 lumped constant vs. arterial plasma glucose [photographs, negative], undated
53 31
516 arterial plasma glucose concentration vs. duration of infusion [photographs, negative], undated
53 32
517 determination of lumped constants during hyperglycemia state [photographs, negative], undated
53 33
518 arterial plasma glucose concentration vs. rate constants in grey and white matter [photographs, negative], undated
53 34
519 lumped constant vs. arterial plasma glucose concentration [photographs, negative], undated
53 35
520 lack of uptake of [32p] G-6-P [photographs, negative], undated
53 36
521 Hawkins brain, DG-6-P graphs [photographs, negative], undated
53 37
522 stimulation of sciatic nerve [photographs, negative], undated
53 38
523 cytochemical localization of G-6-P [photographs, negative], undated
53 39